Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,32,1.25 [1.1-1.42],0.000611532969499985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,2.98 [1.57-5.67],0.000852949021471485,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.59 [1.18-2.15],0.00224930486530988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.11 [1.03-1.19],0.0044660399447378,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.76 [0.63-0.92],0.00497708346593726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.53 [0.34-0.83],0.0054959058394945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,2.41 [1.24-4.68],0.00947933436015086,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SERPINB8,Serpin B8,Inverse variance weighted,28,0.89 [0.82-0.97],0.0108128601536263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.56 [1.1-2.21],0.0131280405846316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PKD2,Polycystin-2,Inverse variance weighted,3,0.31 [0.12-0.8],0.0157565964305342,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.68 [0.5-0.94],0.0172549261693414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.95 [1.12-3.4],0.0175617992737289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.6 [0.39-0.91],0.0176889979908398,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,22,1.15 [1.02-1.3],0.0214593995450319,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RBP2,Retinol-binding protein 2,Wald ratio,1,4.14 [1.23-13.95],0.0219699234825363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,22,1.17 [1.02-1.33],0.0229314904173875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CSTB,Cystatin-B,Inverse variance weighted,28,0.83 [0.71-0.98],0.0236008929727427,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRSS2,Trypsin-2,Inverse variance weighted,3,0.58 [0.36-0.93],0.0245332634976253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EPO,Erythropoietin,Inverse variance weighted,5,0.32 [0.12-0.87],0.0249494344175571,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.33 [1.04-1.7],0.0251953598369726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.83 [0.7-0.98],0.0308083478090103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,1.23 [1.02-1.5],0.0322354983968166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,1.28 [1.02-1.62],0.0338156889249058,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.66 [1.04-2.65],0.0349732712461788,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,1.17 [1.01-1.35],0.0350355385303931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.27 [1.02-1.59],0.0353059904727238,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.89 [0.79-0.99],0.0376875992952126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PVR,Poliovirus receptor,Inverse variance weighted,27,0.89 [0.81-0.99],0.0398741697883182,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,1.14 [1-1.3],0.0437306308127694,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,APOA2,Apolipoprotein A-II,Wald ratio,1,0.32 [0.1-0.97],0.0441056157284016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL5RA,Interleukin-5 receptor subunit alpha,Inverse variance weighted,18,0.87 [0.75-1],0.0450094554226967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.18 [1-1.4],0.0455544363380399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SBSN,Suprabasin,Inverse variance weighted,17,1.15 [1-1.31],0.0464910803113182,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CAPG,Macrophage-capping protein,Inverse variance weighted,33,0.87 [0.76-1],0.0484597350869249,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MSLN,Mesothelin,Inverse variance weighted,25,0.87 [0.76-1],0.0494697752168421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,1.13 [1-1.27],0.0511084205991864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.49 [1-2.24],0.0521174619538313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COCH,Cochlin,Inverse variance weighted,17,0.89 [0.79-1],0.0564927842120992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP8,Neutrophil collagenase,Inverse variance weighted,17,0.85 [0.72-1.01],0.0580747681669522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.27 [0.99-1.64],0.058854231366915,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.88 [0.77-1],0.0589341037261237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Wald ratio,1,1.27 [0.99-1.63],0.0593282595466762,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,37,1.15 [0.99-1.32],0.0593416975252517,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BSG,Basigin,Wald ratio,1,0.6 [0.35-1.02],0.0600704828695666,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,2.14 [0.97-4.74],0.0605024655313859,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.8 [0.97-3.34],0.0615078397909398,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.29 [0.99-1.69],0.062262454756044,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.27 [0.07-1.07],0.0624678892209034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,0.46 [0.21-1.05],0.0660067811635539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MFGE8,Lactadherin,Inverse variance weighted,11,0.82 [0.66-1.02],0.0685556060895449,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CRH,Corticoliberin,Inverse variance weighted,11,1.2 [0.99-1.47],0.0694105929471573,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GRN,Progranulin,Inverse variance weighted,7,0.8 [0.63-1.02],0.0696549755969922,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,1.2 [0.98-1.47],0.0714180722354644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.41 [0.15-1.08],0.0723020095565679,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,19,0.86 [0.73-1.01],0.0731657084208131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.09 [0.99-1.19],0.0732893866356189,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD302,CD302 antigen,Inverse variance weighted,9,0.8 [0.62-1.02],0.0733836828728866,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.41 [0.96-2.07],0.0763204529188773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.57 [0.95-2.58],0.0766537532310359,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.66 [0.42-1.05],0.0772303026679343,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.45 [0.96-2.2],0.0775060680879101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.18 [0.03-1.23],0.0798297119452361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRELP,Prolargin,Inverse variance weighted,9,1.21 [0.98-1.51],0.081198767722959,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VWC2,Brorin,Inverse variance weighted,22,1.18 [0.98-1.42],0.0815309555300414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.81 [0.63-1.03],0.0827504893309131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD2,T-cell surface antigen CD2,Wald ratio,1,0.18 [0.02-1.27],0.084667600081867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,3,0.56 [0.29-1.08],0.0851294351593895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPON1,Spondin-1,Inverse variance weighted,21,1.17 [0.98-1.41],0.0874900286335079,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RTBDN,Retbindin,Inverse variance weighted,3,1.56 [0.93-2.61],0.0896363099341416,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,4,1.93 [0.9-4.17],0.0918555105768983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,1.18 [0.97-1.43],0.0923889789659233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.1 [0.98-1.24],0.0945958447885709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NXPH3,Neurexophilin-3,Inverse variance weighted,11,1.2 [0.97-1.49],0.0961903414673592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PKD1,Polycystin-1,Inverse variance weighted,12,1.24 [0.96-1.59],0.0974671150280778,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.29 [0.95-1.73],0.0995451208147215,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,0.74 [0.52-1.06],0.100787065404189,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.29 [0.95-1.75],0.101764385682691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.84 [0.68-1.03],0.101810202469572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,1.55 [0.91-2.61],0.104463644759095,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD83,CD83 antigen,Inverse variance weighted,5,1.36 [0.94-1.97],0.106094212743879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,12,0.79 [0.59-1.05],0.10623666376728,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.71 [0.89-3.3],0.1068018221853,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,1.2 [0.96-1.49],0.108001081953075,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NPTXR,Neuronal pentraxin receptor,Inverse variance weighted,11,1.07 [0.99-1.16],0.108032876853906,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.11 [0.98-1.25],0.109827906907403,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.85 [0.69-1.04],0.111491534703946,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,0.8 [0.61-1.05],0.112112061828636,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PLIN3,Perilipin-3,Wald ratio,1,2.29 [0.82-6.36],0.112404646933598,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,0.89 [0.78-1.03],0.113350476274461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Wald ratio,1,1.65 [0.89-3.08],0.113544285710542,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,30,1.06 [0.98-1.15],0.115723725364137,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.76 [0.53-1.07],0.117970534481306,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PCDH1,Protocadherin-1,Wald ratio,1,0.49 [0.2-1.21],0.121873054507168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.81 [0.61-1.06],0.122399423954233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,F3,Tissue factor,Inverse variance weighted,11,0.81 [0.61-1.06],0.122866238612116,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NUCB2,Nucleobindin-2,Inverse variance weighted,24,0.87 [0.73-1.04],0.124052776420174,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,0.87 [0.74-1.04],0.125186593820575,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,Inverse variance weighted,11,0.82 [0.64-1.06],0.125444000813596,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.72 [0.86-3.45],0.12572443654395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,2.72 [0.76-9.8],0.125726936450834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,0.94 [0.88-1.02],0.125839034831142,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,1.17 [0.96-1.42],0.126368685287144,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,1.09 [0.98-1.22],0.12676709244417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,1.34 [0.92-1.94],0.127525932660771,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.86 [0.71-1.04],0.129037340720306,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,16,0.87 [0.74-1.04],0.129997331698122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL17C,Interleukin-17C,Inverse variance weighted,3,0.66 [0.38-1.13],0.130746001906696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ACP6,Lysophosphatidic acid phosphatase type 6,Inverse variance weighted,40,1.08 [0.98-1.2],0.133723921477252,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.47 [0.89-2.45],0.13542150114209,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.16 [0.95-1.42],0.136831240737409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CDH17,Cadherin-17,Inverse variance weighted,14,1.18 [0.95-1.48],0.139497829367233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.07 [0.98-1.17],0.140726295965858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.07 [0.98-1.18],0.147429644571846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.72 [0.45-1.13],0.147909639144381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1.11 [0.96-1.27],0.148387005576304,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.19 [0.94-1.52],0.149594575838057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.18 [0.94-1.47],0.14970170407863,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,0.92 [0.82-1.03],0.152405141890777,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CX3CL1,Fractalkine,Inverse variance weighted,9,1.31 [0.9-1.9],0.152975606947376,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.08 [0.97-1.21],0.154906510684861,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CA3,Carbonic anhydrase 3,Inverse variance weighted,6,0.72 [0.46-1.13],0.155646839072984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,0.34 [0.08-1.5],0.155994634510877,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NRP2,Neuropilin-2,Inverse variance weighted,11,0.79 [0.57-1.09],0.15636850017425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,APOA4,Apolipoprotein A-IV,Wald ratio,1,0.27 [0.04-1.66],0.156485739621083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.76 [0.8-3.86],0.157740157237089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OGN,Mimecan,Inverse variance weighted,30,1.12 [0.96-1.31],0.158301444038503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,Inverse variance weighted,44,1.06 [0.98-1.14],0.159278227980526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,14,0.86 [0.7-1.06],0.159557368079351,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.21 [0.93-1.58],0.164331448280604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,1.24 [0.92-1.67],0.165934118544105,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,14,0.9 [0.77-1.05],0.167218724110476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.14 [0.95-1.37],0.168284943496318,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FAM3B,Protein FAM3B,Inverse variance weighted,18,0.92 [0.81-1.04],0.168652255559625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.73 [0.47-1.14],0.168865807780646,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.51 [0.84-2.72],0.169826461026649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTSE,Cathepsin E,Inverse variance weighted,14,1.12 [0.95-1.33],0.171743281467353,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.84 [0.66-1.08],0.17715529439178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OSM,Oncostatin-M,Wald ratio,1,2.08 [0.72-6.05],0.177455367950266,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CALB1,Calbindin,Inverse variance weighted,2,0.56 [0.24-1.31],0.179316057714826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RGMA,Repulsive guidance molecule A,Inverse variance weighted,12,0.87 [0.72-1.06],0.179964639435081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.9 [0.76-1.05],0.180302183935826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.81 [0.6-1.1],0.180668396893679,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.55 [0.23-1.32],0.181105426934524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,3.16 [0.58-17.29],0.185135917585874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1.17 [0.93-1.49],0.186742581146004,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NECTIN4,Nectin-4,Inverse variance weighted,7,1.16 [0.93-1.45],0.187783607808629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.23 [0.9-1.68],0.191693987615816,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.31 [0.87-1.95],0.193203648660518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DSC2,Desmocollin-2,Inverse variance weighted,9,0.85 [0.66-1.09],0.193530073187203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.31 [0.87-1.99],0.199643506177834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.2 [0.91-1.59],0.201176559143768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,0.86 [0.68-1.09],0.202021654095691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,1.37 [0.84-2.21],0.203383003990456,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.17 [0.92-1.5],0.205697059893458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,9,1.14 [0.93-1.41],0.206517053490776,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.75 [0.47-1.18],0.207222435528083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.89 [0.75-1.06],0.207295480697623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.94 [0.85-1.04],0.211183169201108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1.31 [0.86-2],0.213459354376643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.23 [0.89-1.7],0.216511363689003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.83 [0.62-1.12],0.216645979669688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1.39 [0.82-2.35],0.219441214719882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.18 [0.9-1.56],0.22474618328247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KIF1C,Kinesin-like protein KIF1C,Wald ratio,1,3.72 [0.44-31.12],0.225387999372984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PXN,Paxillin,Inverse variance weighted,26,0.91 [0.78-1.06],0.225544102621348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,1.09 [0.95-1.25],0.226066364428729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,43,1.04 [0.97-1.12],0.228063769522095,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,0.58 [0.23-1.42],0.23147576227156,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPP1,Osteopontin,Inverse variance weighted,8,0.74 [0.44-1.22],0.231930134199691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.72 [0.42-1.23],0.232119238255037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SUSD4,Sushi domain-containing protein 4,Inverse variance weighted,15,0.82 [0.6-1.13],0.234596497440467,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AGRN,Agrin,Inverse variance weighted,17,0.88 [0.7-1.09],0.237726184535587,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GRP,Gastrin-releasing peptide,Inverse variance weighted,12,1.09 [0.94-1.27],0.239216994620711,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,1.13 [0.92-1.4],0.244009213298656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PI3,Elafin,Inverse variance weighted,10,1.14 [0.91-1.42],0.244274199842271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.9 [0.75-1.08],0.245186099190094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AHNAK2,Protein AHNAK2,Inverse variance weighted,4,1.21 [0.88-1.67],0.24557607109172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP13,Collagenase 3,Inverse variance weighted,2,0.43 [0.1-1.81],0.251502474148704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,1.35 [0.81-2.25],0.254464779771034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,1.06 [0.96-1.18],0.257697090506729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.48 [0.75-2.93],0.259092732360105,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,1.11 [0.92-1.34],0.259565066138543,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.49 [0.74-3.03],0.264481716428819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,0.86 [0.65-1.12],0.265101658491568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,7,0.71 [0.38-1.31],0.266759838483711,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,0.76 [0.47-1.23],0.267748431688678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,STC2,Stanniocalcin-2,Inverse variance weighted,3,0.55 [0.19-1.58],0.269753672877301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,11,0.82 [0.57-1.17],0.270975111466091,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,0.89 [0.73-1.09],0.273230257246955,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,0.72 [0.4-1.3],0.274748038699383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,0.81 [0.56-1.18],0.274847201510834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.77 [0.49-1.23],0.276227887032055,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,0.91 [0.77-1.08],0.277751188812747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD46,Membrane cofactor protein,Wald ratio,1,1.59 [0.69-3.65],0.278927936995771,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DTNB,Dystrobrevin beta,Inverse variance weighted,2,2.43 [0.49-12.13],0.279962738268578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.36 [0.78-2.39],0.281738769664036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AGRP,Agouti-related protein,Inverse variance weighted,3,1.52 [0.71-3.28],0.28491789817865,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLK8,Kallikrein-8,Inverse variance weighted,12,0.89 [0.72-1.1],0.289836593022928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TPR,Nucleoprotein TPR,Wald ratio,1,1.86 [0.59-5.91],0.289841554958709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,0.79 [0.51-1.22],0.291152399056518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.22 [0.85-1.75],0.291669839606838,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRTN3,Myeloblastin,Inverse variance weighted,21,0.92 [0.79-1.07],0.293176444411539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.36 [0.77-2.39],0.293868549076607,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1.09 [0.93-1.27],0.293907397048582,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.05 [0.96-1.16],0.294128770132807,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OGFR,Opioid growth factor receptor,Inverse variance weighted,2,1.6 [0.66-3.87],0.294690689013384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LEPR,Leptin receptor,Inverse variance weighted,8,0.85 [0.62-1.16],0.297189022982474,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Wald ratio,1,0.6 [0.23-1.57],0.298340273238028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.91 [0.77-1.08],0.29859410855671,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OPTC,Opticin,Inverse variance weighted,9,1.09 [0.92-1.29],0.298994873691064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IFNL1,Interferon lambda-1,Wald ratio,1,0.41 [0.07-2.22],0.300381956337169,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,28,0.94 [0.85-1.05],0.300591980034751,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.39 [0.74-2.59],0.301742657445753,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SEPTIN8,Septin-8,Inverse variance weighted,2,1.32 [0.78-2.22],0.301768620960104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,1.08 [0.93-1.26],0.302063688473149,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,INHBC,Inhibin beta C chain,Inverse variance weighted,29,1.08 [0.94-1.24],0.3021684712567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.61 [0.65-3.97],0.303472997373366,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,WFDC1,WAP four-disulfide core domain protein 1,Inverse variance weighted,6,0.87 [0.67-1.14],0.306175411393781,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.06 [0.95-1.19],0.306982989778315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,UNC5D,Netrin receptor UNC5D,Wald ratio,1,0.05 [0-16.78],0.309800811032541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPRR3,Small proline-rich protein 3,Inverse variance weighted,11,0.85 [0.62-1.16],0.31162901280318,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,7,1.16 [0.87-1.55],0.312641426471189,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,1.53 [0.67-3.52],0.313369638779205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.11 [0.91-1.36],0.314392858499565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,3,1.39 [0.73-2.63],0.315894665393749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,0.84 [0.6-1.18],0.31813134045705,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.58 [0.64-3.88],0.318377433429585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CHGB,Secretogranin-1,Inverse variance weighted,27,0.93 [0.8-1.08],0.320429302541132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LMNB2,Lamin-B2,Wald ratio,1,2.51 [0.41-15.51],0.321402725710567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GUCA2A,Guanylin,Inverse variance weighted,9,0.82 [0.55-1.22],0.322126322414609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.55 [0.17-1.8],0.325382832295688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,2.28 [0.44-11.84],0.325572896907231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PYY,Peptide YY,Inverse variance weighted,6,0.86 [0.64-1.16],0.326673964220614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.86 [0.64-1.16],0.327357882279862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HJV,Hemojuvelin,Wald ratio,1,1.23 [0.81-1.84],0.328607595590936,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.67 [0.29-1.52],0.332230788422606,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CALCA,Calcitonin,Inverse variance weighted,5,0.67 [0.29-1.52],0.333441624604991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.2 [0.83-1.74],0.334311983390185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.19 [0.84-1.67],0.334748034944008,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.05 [0.95-1.17],0.335911666075034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,0.6 [0.21-1.69],0.336324796312025,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AREG,Amphiregulin,Inverse variance weighted,3,0.79 [0.49-1.28],0.339791978418172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP10,Stromelysin-2,Inverse variance weighted,22,0.91 [0.74-1.11],0.341832263292933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.94 [0.83-1.07],0.343091908819279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.91 [0.74-1.11],0.346477677159355,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,6,1.18 [0.84-1.64],0.346580029475068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,1.05 [0.95-1.16],0.348216421332436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SDC1,Syndecan-1,Inverse variance weighted,2,0.74 [0.4-1.38],0.349826219009253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,1.18 [0.83-1.67],0.350570158452074,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VASN,Vasorin,Inverse variance weighted,14,1.07 [0.93-1.22],0.354807903621773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,P4HB,Protein disulfide-isomerase,Inverse variance weighted,2,0.58 [0.19-1.83],0.356499978713334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.89 [0.7-1.13],0.357756480414919,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLAMF6,SLAM family member 6,Inverse variance weighted,2,0.83 [0.56-1.23],0.360324900035726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.2 [0.81-1.79],0.361590110685104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1.09 [0.91-1.3],0.362613868212972,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.71 [0.33-1.5],0.36403758972527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.78 [0.45-1.34],0.365026693669327,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTSD,Cathepsin D,Inverse variance weighted,17,1.1 [0.9-1.35],0.36536143616931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,0.45 [0.08-2.52],0.365475037716518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,STC1,Stanniocalcin-1,Inverse variance weighted,2,0.6 [0.2-1.81],0.36571237549604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,0.8 [0.48-1.31],0.366407926919408,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.25 [0.77-2.02],0.366866050248948,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NPPC,C-type natriuretic peptide,Wald ratio,1,0.44 [0.07-2.61],0.367043931760796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,22,1.07 [0.93-1.22],0.367071527439541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,1.38 [0.69-2.78],0.367392071077055,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.9 [0.73-1.13],0.368822502305844,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD70,CD70 antigen,Inverse variance weighted,28,0.94 [0.82-1.08],0.369821529935982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.24 [0.77-2],0.370502984291894,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.9 [0.72-1.13],0.37082745473493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,3,1.2 [0.81-1.77],0.372872740614358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.06 [0.93-1.21],0.374595142482616,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTSV,Cathepsin L2,Inverse variance weighted,11,1.13 [0.86-1.47],0.377983206727202,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,2.68 [0.3-23.96],0.377995138939534,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VWC2L,von Willebrand factor C domain-containing protein 2-like,Wald ratio,1,0.69 [0.3-1.59],0.378956501889529,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.17 [0.82-1.66],0.380083784237263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CPA1,Carboxypeptidase A1,Inverse variance weighted,2,0.82 [0.52-1.28],0.380201382727175,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ENAH,Protein enabled homolog,Inverse variance weighted,2,0.59 [0.18-1.94],0.382119574843793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,1.24 [0.77-2],0.382863575445988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.72 [0.35-1.5],0.383438170190857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MME,Neprilysin,Inverse variance weighted,3,1.49 [0.61-3.64],0.384301021103714,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1.21 [0.78-1.88],0.386157518441436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.95 [0.84-1.07],0.386564652416931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.68 [0.29-1.61],0.386983677903147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL16,Pro-interleukin-16,Inverse variance weighted,16,1.08 [0.91-1.29],0.388021678129021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD48,CD48 antigen,Inverse variance weighted,18,0.95 [0.84-1.07],0.388040142011901,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,0.79 [0.46-1.35],0.389396327050593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PCDHB15,Protocadherin beta-15,Inverse variance weighted,29,0.95 [0.84-1.07],0.390584435776566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CDH1,Cadherin-1,Wald ratio,1,2.01 [0.41-9.84],0.390899498829818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,2.41 [0.32-18.19],0.393288177741058,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCGB1A1,Uteroglobin,Inverse variance weighted,12,1.11 [0.87-1.41],0.393962931704852,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,0.68 [0.28-1.66],0.395252605079331,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.42 [0.63-3.23],0.397425553260457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ARHGEF5,Rho guanine nucleotide exchange factor 5,Inverse variance weighted,19,0.94 [0.81-1.09],0.398302590140655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,0.89 [0.67-1.18],0.398993713764959,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD8A,T-cell surface glycoprotein CD8 alpha chain,Inverse variance weighted,9,0.84 [0.56-1.26],0.399300184374098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTSO,Cathepsin O,Inverse variance weighted,6,1.24 [0.75-2.05],0.40114661344218,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.35 [0.67-2.7],0.403744233500944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,2,0.61 [0.2-1.93],0.403999452844675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MATN2,Matrilin-2,Inverse variance weighted,18,0.91 [0.72-1.14],0.405640623078862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,6,0.88 [0.65-1.19],0.410398424158044,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PENK,Proenkephalin-A,Inverse variance weighted,19,1.08 [0.9-1.31],0.411170741096894,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.85 [0.59-1.25],0.413181971195538,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LGALS3,Galectin-3,Inverse variance weighted,25,0.94 [0.81-1.09],0.414919921861765,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,1.09 [0.89-1.33],0.414940838235054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,10,0.94 [0.8-1.1],0.416349281775955,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,1.79 [0.44-7.27],0.416937770191804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1.06 [0.92-1.22],0.42031332697436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.07 [0.9-1.27],0.422068676187101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,2,0.76 [0.39-1.49],0.423577825954993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CFD,Complement factor D,Inverse variance weighted,11,1.11 [0.86-1.43],0.424097055238062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,14,1.1 [0.88-1.37],0.424666245351191,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MILR1,Allergin-1,Inverse variance weighted,33,1.03 [0.95-1.12],0.426385470662565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.85 [0.57-1.27],0.42870815382561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,0.94 [0.8-1.1],0.430447949520609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SELE,E-selectin,Inverse variance weighted,4,0.76 [0.38-1.52],0.431807460523829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CDH3,Cadherin-3,Inverse variance weighted,2,1.41 [0.6-3.33],0.431975076102466,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,0.95 [0.84-1.08],0.434619674719822,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.91 [0.72-1.15],0.435724121137891,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HEG1,Protein HEG homolog 1,Inverse variance weighted,4,1.37 [0.62-3.05],0.435981027255773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLK10,Kallikrein-10,Inverse variance weighted,15,0.93 [0.77-1.12],0.436949928472624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,1.09 [0.87-1.37],0.437075927334756,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLK14,Kallikrein-14,Inverse variance weighted,15,1.07 [0.91-1.25],0.437331059090059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,17,0.94 [0.8-1.1],0.437621975223526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLK13,Kallikrein-13,Inverse variance weighted,11,1.06 [0.91-1.23],0.437710330807201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.24 [0.72-2.13],0.4387676759519,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRSS8,Prostasin,Inverse variance weighted,5,1.23 [0.73-2.06],0.439608372414941,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,XCL1,Lymphotactin,Inverse variance weighted,31,1.05 [0.93-1.17],0.44408650301104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1.11 [0.85-1.44],0.44642311558546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,0.59 [0.15-2.31],0.449623542347456,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRSS27,Serine protease 27,Inverse variance weighted,5,0.85 [0.57-1.29],0.450680115499123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.92 [0.73-1.15],0.451324007459042,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,0.91 [0.7-1.17],0.452844950634472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.05 [0.93-1.19],0.452946303085179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.11 [0.85-1.44],0.453790402595383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCN5,CCN family member 5,Inverse variance weighted,8,0.8 [0.45-1.43],0.45424405912154,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SNCG,Gamma-synuclein,Inverse variance weighted,36,1.04 [0.93-1.17],0.454837887862044,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,1.08 [0.89-1.31],0.454985578611383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,21,1.06 [0.91-1.23],0.457209837074407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.86 [0.57-1.29],0.457402287083566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MB,Myoglobin,Wald ratio,1,0.48 [0.07-3.39],0.458711817826578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CST7,Cystatin-F,Inverse variance weighted,39,0.96 [0.86-1.07],0.462166232387424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EDN1,Endothelin-1,Inverse variance weighted,3,1.16 [0.78-1.7],0.462432627902278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,C7,Complement component C7,Inverse variance weighted,38,1.04 [0.94-1.15],0.465692095589679,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,0.92 [0.74-1.15],0.466481967867942,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.04 [0.93-1.16],0.467444907437841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.16 [0.78-1.72],0.469769580622413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1.06 [0.9-1.25],0.47046338814987,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.13 [0.82-1.55],0.472102800803541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,0.79 [0.41-1.51],0.473930613957471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.93 [0.75-1.14],0.474537688661034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CPB1,Carboxypeptidase B,Wald ratio,1,1.28 [0.65-2.53],0.480426050888257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NRP1,Neuropilin-1,Inverse variance weighted,12,0.93 [0.76-1.14],0.483041663725172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ELN,Elastin,Inverse variance weighted,2,1.42 [0.53-3.75],0.484736979309926,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPARCL1,SPARC-like protein 1,Inverse variance weighted,35,1.04 [0.93-1.15],0.486457980722985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",Inverse variance weighted,11,1.13 [0.8-1.59],0.48714885951447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,40,1.04 [0.93-1.15],0.488265150609962,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,1.28 [0.64-2.54],0.488957955613714,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,1.03 [0.95-1.11],0.492217638793989,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.36 [0.56-3.32],0.493025726220983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD276,CD276 antigen,Inverse variance weighted,20,0.96 [0.85-1.08],0.493163060481247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MUC13,Mucin-13,Inverse variance weighted,9,1.15 [0.77-1.72],0.497086251021247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,0.97 [0.9-1.06],0.499075855056787,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,2 [0.27-15.05],0.500844166203931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,0.95 [0.81-1.11],0.50145995669619,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,0.94 [0.8-1.12],0.502116149422631,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.93 [0.74-1.16],0.502533539251081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.06 [0.89-1.26],0.503211480243141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.97 [0.87-1.07],0.504990993945735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.05 [0.9-1.23],0.506217734532092,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.11 [0.81-1.54],0.50657144777527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PALM,Paralemmin-1,Inverse variance weighted,6,1.14 [0.78-1.67],0.506950105916508,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,0.93 [0.73-1.16],0.507885530934072,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,0.93 [0.75-1.15],0.508043675894087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.91 [0.7-1.19],0.50840638754178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,5,1.21 [0.69-2.1],0.509420139817833,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RSPO1,R-spondin-1,Inverse variance weighted,5,1.11 [0.82-1.5],0.510890372188348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,17,1.07 [0.88-1.3],0.5122680283773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.83 [0.48-1.45],0.514660444563918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MDK,Midkine,Inverse variance weighted,4,1.26 [0.63-2.52],0.514685873571037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,1.14 [0.77-1.69],0.516022697983758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,UMOD,Uromodulin,Inverse variance weighted,29,0.97 [0.87-1.07],0.516759038839475,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.91 [0.69-1.2],0.517533273253625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.89 [0.62-1.28],0.517981948636371,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ALCAM,CD166 antigen,Inverse variance weighted,6,1.17 [0.73-1.88],0.520686540460644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.82 [0.44-1.52],0.520699495260748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PGF,Placenta growth factor,Inverse variance weighted,2,0.54 [0.08-3.62],0.521381163534553,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,0.92 [0.71-1.19],0.522432320343064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.06 [0.88-1.27],0.523668516007761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CHRDL2,Chordin-like protein 2,Inverse variance weighted,7,1.12 [0.79-1.58],0.523688067847641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.81 [0.43-1.54],0.524478937183121,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.18 [0.71-1.96],0.525905357813065,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.94 [0.77-1.14],0.525994820895832,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD160,CD160 antigen,Inverse variance weighted,11,0.94 [0.79-1.13],0.528485035263069,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,26,1.03 [0.94-1.13],0.530974303694399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,0.75 [0.31-1.84],0.53111216970398,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,0.96 [0.85-1.08],0.532309912500336,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,1.07 [0.87-1.32],0.532371043961671,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,0.96 [0.85-1.09],0.536336698306778,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,1.09 [0.84-1.41],0.53708292520707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GPD1,Glycerol-3-phosphate dehydrogenase,Wald ratio,1,1.46 [0.44-4.87],0.538726806368971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.83 [0.46-1.51],0.541077935259153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,1.03 [0.94-1.14],0.543319452294177,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,0.93 [0.74-1.17],0.544412714545052,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,2,0.77 [0.33-1.79],0.547749422803623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.08 [0.85-1.37],0.549460068346447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.94 [0.76-1.16],0.550072380238517,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.9 [0.63-1.28],0.55320429388705,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,19,0.96 [0.82-1.11],0.553409653015603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,0.95 [0.8-1.12],0.553661156006458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DPT,Dermatopontin,Inverse variance weighted,21,1.06 [0.87-1.29],0.554996569883812,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ITGA5,Integrin alpha-5,Wald ratio,1,1.45 [0.42-5.06],0.556058947108552,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ANGPTL2,Angiopoietin-related protein 2,Wald ratio,1,0.59 [0.1-3.48],0.556456777619974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,0.89 [0.62-1.3],0.557019815146678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,0.73 [0.26-2.09],0.560233698644633,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,0.88 [0.56-1.37],0.562729353451473,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,5,0.92 [0.69-1.22],0.563082293525282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.96 [0.85-1.1],0.565031464219225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LUZP2,Leucine zipper protein 2,Inverse variance weighted,8,0.91 [0.67-1.24],0.567078639632488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CST3,Cystatin-C,Inverse variance weighted,10,1.07 [0.85-1.33],0.568528495421096,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,0.95 [0.78-1.15],0.569288514060086,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.96 [0.84-1.1],0.56998677066226,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,1.1 [0.79-1.53],0.570989999962778,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,0.96 [0.83-1.11],0.571071240985193,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.56 [0.07-4.19],0.572651842891568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,1.08 [0.82-1.42],0.573262271292429,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DSG2,Desmoglein-2,Inverse variance weighted,11,0.92 [0.69-1.23],0.57405756764969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VGF,Neurosecretory protein VGF,Wald ratio,1,0.56 [0.07-4.23],0.574615328411513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1.04 [0.91-1.2],0.574876385509976,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,1.17 [0.67-2.03],0.575363188119828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NFASC,Neurofascin,Inverse variance weighted,15,0.95 [0.79-1.14],0.57585771153847,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HMOX2,Heme oxygenase 2,Inverse variance weighted,2,1.46 [0.39-5.51],0.578146680476701,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,0.97 [0.88-1.07],0.578246127794334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL15,Interleukin-15,Wald ratio,1,6.13 [0.01-3712.43],0.579034550142139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.14 [0.72-1.78],0.581332557263051,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,1.06 [0.85-1.32],0.582874614152775,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CST5,Cystatin-D,Inverse variance weighted,37,1.03 [0.93-1.14],0.583761148386322,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL14,C-X-C motif chemokine 14,Wald ratio,1,1.52 [0.34-6.81],0.585770764466936,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,5,0.88 [0.57-1.38],0.586865834625429,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LPCAT2,Lysophosphatidylcholine acyltransferase 2,Inverse variance weighted,5,1.12 [0.74-1.68],0.587504530215987,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,THBS2,Thrombospondin-2,Inverse variance weighted,16,0.95 [0.79-1.14],0.58906559171949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GPC1,Glypican-1,Inverse variance weighted,17,1.05 [0.87-1.28],0.589603962254133,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TMSB10,Thymosin beta-10,Wald ratio,1,0.71 [0.2-2.52],0.591666384617314,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,0.98 [0.89-1.07],0.592999283387574,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1.02 [0.95-1.1],0.59400114502493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FABP6,Gastrotropin,Wald ratio,1,0.86 [0.49-1.5],0.594911879138094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.04 [0.9-1.2],0.595158254535367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,0.93 [0.69-1.23],0.596559359850145,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.8 [0.34-1.85],0.59729325828446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,0.95 [0.8-1.14],0.597742818303413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.86 [0.5-1.49],0.598457672154673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.97 [0.88-1.07],0.599933773357786,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,0.62 [0.1-3.76],0.602976941410667,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCN4,CCN family member 4,Inverse variance weighted,27,0.97 [0.85-1.1],0.603704592489251,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.05 [0.88-1.26],0.603982532203351,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,0.97 [0.88-1.07],0.605238774545444,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL18,Interleukin-18,Inverse variance weighted,16,0.9 [0.61-1.33],0.60704656430967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.42 [0.37-5.49],0.609280920356152,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CDH6,Cadherin-6,Inverse variance weighted,29,0.97 [0.86-1.09],0.610123432699226,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,0.96 [0.81-1.13],0.610882642323369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.88 [0.53-1.45],0.611085057495723,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.81 [0.36-1.83],0.611486886050697,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,0.97 [0.86-1.09],0.613133904370846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GPR158,Probable G-protein coupled receptor 158,Wald ratio,1,0.74 [0.23-2.4],0.618834614536638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,0.96 [0.81-1.13],0.61947869571932,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.36 [0.4-4.61],0.619890039691271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,1.05 [0.87-1.26],0.624632861603359,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.92 [0.64-1.31],0.625081870857068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.94 [0.73-1.21],0.628659698999638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.94 [0.74-1.2],0.629115990061132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,1.04 [0.88-1.24],0.630061130122313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLGN,Calmegin,Inverse variance weighted,23,0.97 [0.86-1.1],0.630768823735144,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.94 [0.75-1.19],0.631424682086526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,1.14 [0.67-1.91],0.632031550486307,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PSAP,Prosaposin,Inverse variance weighted,5,0.87 [0.5-1.53],0.633510409190865,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PALM2,Paralemmin-2,Inverse variance weighted,8,1.08 [0.78-1.52],0.635818195179285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,31,0.97 [0.84-1.11],0.636325444883078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VCAN,Versican core protein,Inverse variance weighted,31,1.03 [0.91-1.17],0.636367483373348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,0.97 [0.87-1.09],0.637226146798586,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,3,1.17 [0.61-2.25],0.638869250279651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MPO,Myeloperoxidase,Inverse variance weighted,11,1.05 [0.87-1.26],0.639434027122524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL19,Interleukin-19,Inverse variance weighted,11,0.95 [0.76-1.18],0.639463763986285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.94 [0.72-1.23],0.641745202496835,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,0.97 [0.84-1.11],0.64259784911617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LAYN,Layilin,Inverse variance weighted,20,0.95 [0.77-1.18],0.642901824119566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.67 [0.12-3.67],0.643327318875477,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DRAXIN,Draxin,Inverse variance weighted,13,1.04 [0.89-1.21],0.643433333129135,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD7,T-cell antigen CD7,Inverse variance weighted,8,1.05 [0.85-1.3],0.644884508927541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,1.03 [0.9-1.18],0.64908065544115,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTSL,Cathepsin L1,Wald ratio,1,1.45 [0.29-7.23],0.650236177971524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.12 [0.68-1.86],0.650287668177389,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LGALS1,Galectin-1,Inverse variance weighted,6,1.05 [0.84-1.31],0.650761112668351,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,0.98 [0.89-1.08],0.651507011817479,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DLK1,Protein delta homolog 1,Inverse variance weighted,25,1.03 [0.9-1.17],0.655092423995858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.75 [0.21-2.67],0.655425807343361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.96 [0.79-1.16],0.656310530039935,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.13 [0.65-1.97],0.656953344523076,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.85 [0.42-1.73],0.660755158347061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,1.19 [0.54-2.63],0.661018870393436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.03 [0.91-1.16],0.661292845847156,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.84 [0.38-1.87],0.662624593069826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.03 [0.9-1.18],0.663463684885858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NOMO1,Nodal modulator 1,Inverse variance weighted,2,1.13 [0.66-1.92],0.665089887572608,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,0.92 [0.62-1.36],0.66708367752616,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,1.12 [0.66-1.91],0.66789547653185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.85 [0.4-1.81],0.670166581267296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.9 [0.56-1.45],0.670552497598339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,2,1.25 [0.45-3.48],0.671148284602757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COLEC12,Collectin-12,Inverse variance weighted,11,0.93 [0.66-1.31],0.672284359972018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NECTIN2,Nectin-2,Inverse variance weighted,5,0.94 [0.7-1.26],0.672512312937316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,0.63 [0.07-5.42],0.672582149945815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD164,Sialomucin core protein 24,Inverse variance weighted,3,1.1 [0.7-1.73],0.67771323428358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.89 [0.52-1.53],0.678725586825687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.03 [0.89-1.2],0.680329024080576,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,13,0.96 [0.8-1.16],0.68098279949183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RSPO3,R-spondin-3,Inverse variance weighted,6,1.08 [0.74-1.59],0.68423711691463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,16,0.96 [0.81-1.15],0.685126561826016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.11 [0.66-1.89],0.688427974366677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD27,CD27 antigen,Inverse variance weighted,9,1.05 [0.82-1.36],0.689595804584803,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.79 [0.24-2.64],0.700438629197198,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.94 [0.67-1.31],0.70739576095589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.05 [0.8-1.39],0.707711550429395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,18,1.02 [0.9-1.16],0.707762252147926,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.05 [0.82-1.34],0.708790482543753,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,1.05 [0.82-1.34],0.709295708924941,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,0.97 [0.84-1.12],0.712820238756745,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.04 [0.84-1.29],0.716321402542391,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.95 [0.72-1.26],0.717203545546313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.91 [0.54-1.53],0.722404286106593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PCDH7,Protocadherin-7,Inverse variance weighted,3,1.11 [0.61-2.02],0.723233404833619,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FAM3D,Protein FAM3D,Inverse variance weighted,17,0.95 [0.72-1.26],0.724196635636381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.98 [0.87-1.1],0.728605256893886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.73 [0.13-4.27],0.728622137855243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1.04 [0.83-1.3],0.729665456734444,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPON2,Spondin-2,Inverse variance weighted,4,0.95 [0.69-1.3],0.729914654185945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,24,0.98 [0.87-1.1],0.731275243470541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,0.98 [0.85-1.12],0.734777158200142,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1.08 [0.68-1.72],0.736491848533084,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,S100P,Protein S100-P,Inverse variance weighted,2,0.81 [0.24-2.76],0.741611104064896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,1.04 [0.83-1.29],0.741751641211394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Inverse variance weighted,3,0.94 [0.67-1.33],0.742158933018696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.02 [0.89-1.17],0.742342358180755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LCN15,Lipocalin-15,Inverse variance weighted,20,1.02 [0.91-1.15],0.744194102514426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,10,0.96 [0.75-1.23],0.744594845231348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.08 [0.68-1.72],0.746791319513557,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,Wald ratio,1,1.4 [0.18-11.04],0.748799321728867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.97 [0.82-1.15],0.750186416574041,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.92 [0.56-1.52],0.750705797048132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.91 [0.49-1.67],0.750765468224974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LGALS9,Galectin-9,Inverse variance weighted,26,1.03 [0.87-1.21],0.752536074603862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.98 [0.84-1.13],0.756831293742124,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,1.07 [0.69-1.66],0.757619655261513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.94 [0.63-1.39],0.758639047277402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,0.98 [0.85-1.13],0.758690052542574,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.87 [0.36-2.11],0.760559155325528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.04 [0.82-1.32],0.761459924505785,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,1.05 [0.76-1.45],0.762082544767263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.8 [0.19-3.39],0.762697221108132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.93 [0.56-1.53],0.764201988157311,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OCLN,Occludin,Inverse variance weighted,2,0.79 [0.17-3.76],0.76656289440371,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NEO1,Neogenin,Wald ratio,1,0.86 [0.33-2.29],0.768177749070663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.02 [0.87-1.2],0.769560547814334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CDH2,Cadherin-2,Inverse variance weighted,3,0.88 [0.38-2.06],0.774921239346487,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CST6,Cystatin-M,Inverse variance weighted,2,0.95 [0.66-1.37],0.779953703767547,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,1.04 [0.78-1.39],0.780903948110718,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,REN,Renin,Inverse variance weighted,4,1.04 [0.8-1.35],0.781975237413446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CALB2,Calretinin,Wald ratio,1,0.84 [0.25-2.82],0.782306169028643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,1.08 [0.62-1.88],0.782692228008874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.1 [0.57-2.12],0.783597651707168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.8 [0.16-3.94],0.786093181679551,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CPA2,Carboxypeptidase A2,Inverse variance weighted,17,1.03 [0.81-1.31],0.786729109992311,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,3,1.08 [0.6-1.95],0.787309713374884,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTBS,Di-N-acetylchitobiase,Inverse variance weighted,11,1.01 [0.92-1.12],0.791052689673601,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTSS,Cathepsin S,Inverse variance weighted,23,1.02 [0.88-1.19],0.791090062398954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,1.03 [0.82-1.31],0.792891523017373,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.99 [0.88-1.1],0.79353451922363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCG3,Secretogranin-3,Inverse variance weighted,32,1.02 [0.89-1.17],0.794653438074148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,1.05 [0.74-1.48],0.795079595953779,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.97 [0.76-1.23],0.795344629528587,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP1,Interstitial collagenase,Inverse variance weighted,31,1.02 [0.89-1.17],0.796600570146798,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,36,0.98 [0.84-1.15],0.797587891752256,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.97 [0.76-1.24],0.798448393469433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.01 [0.91-1.14],0.798698510926035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,22,0.98 [0.84-1.14],0.800995738745643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,0.92 [0.48-1.75],0.800999027543754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,1.02 [0.88-1.17],0.803327992373218,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ANXA10,Annexin A10,Wald ratio,1,1.2 [0.28-5.11],0.805061112693366,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LAMB1,Laminin subunit beta-1,Inverse variance weighted,35,0.98 [0.86-1.12],0.806376353804873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DSG3,Desmoglein-3,Inverse variance weighted,7,1.03 [0.79-1.36],0.806665659898885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ANG,Angiogenin,Inverse variance weighted,19,1.02 [0.87-1.19],0.807216073848697,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,4,0.85 [0.24-3.07],0.807503369918393,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,0.97 [0.79-1.2],0.807526132202849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.15 [0.37-3.6],0.807541939354645,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,6,0.94 [0.59-1.52],0.808697880556807,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,0.98 [0.84-1.14],0.808715400379018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.98 [0.8-1.19],0.811377041406716,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLRF1,Killer cell lectin-like receptor subfamily F member 1,Inverse variance weighted,2,0.93 [0.52-1.67],0.817445264457771,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,21,0.99 [0.92-1.07],0.817773784447523,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IDUA,Alpha-L-iduronidase,Inverse variance weighted,35,0.99 [0.88-1.11],0.824226288907849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.06 [0.66-1.7],0.824366059954277,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FBLN2,Fibulin-2,Inverse variance weighted,11,1.02 [0.84-1.25],0.826280881624003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP3,Stromelysin-1,Inverse variance weighted,34,0.98 [0.8-1.19],0.827298855130898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.96 [0.64-1.43],0.827814288425575,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,55,1.01 [0.94-1.08],0.828005827207471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.21 [0.21-6.95],0.828681624103688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.05 [0.68-1.61],0.83726845210461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.92 [0.41-2.06],0.839619350340571,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,1.04 [0.72-1.5],0.841564611163714,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL6R,Interleukin-6 receptor subunit alpha,Inverse variance weighted,56,0.99 [0.92-1.07],0.844258270898419,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.98 [0.8-1.2],0.847165170526885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,2,0.87 [0.22-3.46],0.847718120352806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.05 [0.65-1.69],0.848198662579689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LPO,Lactoperoxidase,Inverse variance weighted,4,0.97 [0.68-1.37],0.850092801442803,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,14,1.02 [0.86-1.19],0.855160086741446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.94 [0.51-1.75],0.856313377603569,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.99 [0.88-1.11],0.857424861373543,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,0.94 [0.48-1.84],0.858076737280161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.98 [0.81-1.19],0.859175725258183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1.03 [0.72-1.49],0.859350299576013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.98 [0.8-1.21],0.86079428644021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,1.05 [0.6-1.83],0.86130955129676,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCGB3A1,Secretoglobin family 3A member 1,Inverse variance weighted,2,0.95 [0.54-1.67],0.863459340254963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.04 [0.68-1.58],0.865108150546848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ITGB6,Integrin beta-6,Inverse variance weighted,11,1.02 [0.78-1.34],0.866683532970965,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,4,0.96 [0.6-1.53],0.867152667617449,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL10,Interleukin-10,Wald ratio,1,1.06 [0.52-2.18],0.867504068475365,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.98 [0.73-1.31],0.868548281162258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLK4,Kallikrein-4,Inverse variance weighted,17,1.01 [0.86-1.2],0.869478356127039,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ANXA5,Annexin A5,Inverse variance weighted,2,0.94 [0.47-1.9],0.87194057880848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL8,Interleukin-8,Inverse variance weighted,6,1.07 [0.47-2.46],0.872697810703597,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,0.98 [0.8-1.21],0.873787875157697,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,1.03 [0.75-1.41],0.875546776254994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNC,Tenascin,Inverse variance weighted,12,1.02 [0.8-1.31],0.876046759557566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PGA4,Pepsin A-4,Inverse variance weighted,2,0.93 [0.35-2.48],0.876953945306776,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PYDC1,Pyrin domain-containing protein 1,Inverse variance weighted,12,1.02 [0.8-1.29],0.878987585448818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,0.98 [0.81-1.2],0.881621733262526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,F11R,Junctional adhesion molecule A,Wald ratio,1,0.91 [0.27-3.08],0.883600582987327,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,1.01 [0.86-1.19],0.883957312763515,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,18,1.01 [0.83-1.24],0.885050323688153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RGMB,RGM domain family member B,Inverse variance weighted,9,1.02 [0.75-1.4],0.885594829808743,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.02 [0.8-1.3],0.885698199306759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,7,1.02 [0.8-1.29],0.886264637685305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRG2,Bone marrow proteoglycan,Wald ratio,1,0.93 [0.36-2.41],0.887128912849135,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP7,Matrilysin,Inverse variance weighted,13,0.98 [0.75-1.28],0.888783835647552,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,1.01 [0.83-1.24],0.890521456536602,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCN3,CCN family member 3,Inverse variance weighted,19,0.98 [0.75-1.29],0.897647904040203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.99 [0.79-1.22],0.897729510208713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.05 [0.48-2.33],0.898166282041523,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1.02 [0.76-1.36],0.898531843596634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1.02 [0.8-1.29],0.899719047860152,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,1.05 [0.5-2.21],0.899799441335834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.02 [0.7-1.49],0.899885239829874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.92 [0.25-3.42],0.899955145471977,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,0.93 [0.31-2.82],0.900481384036725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.96 [0.52-1.79],0.90116455135635,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.99 [0.84-1.16],0.901932065881581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,20,1.01 [0.89-1.14],0.902246843866325,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,0.99 [0.83-1.18],0.904373171587287,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,1.02 [0.71-1.48],0.906239046411624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,5,1.02 [0.69-1.52],0.906494856369646,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,0.95 [0.37-2.43],0.906870686271563,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.96 [0.52-1.79],0.909339332680445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,10,0.98 [0.68-1.4],0.909439162911726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL17D,Interleukin-17D,Inverse variance weighted,15,1.01 [0.83-1.23],0.912589286861745,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL36G,Interleukin-36 gamma,Inverse variance weighted,2,1.06 [0.39-2.9],0.913668360302461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,21,0.99 [0.84-1.17],0.915062494282577,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.99 [0.81-1.21],0.919647947137153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GPR15L,Protein GPR15L,Inverse variance weighted,9,0.99 [0.78-1.26],0.922253118305233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,0.97 [0.52-1.82],0.922769702309255,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.01 [0.9-1.12],0.924719871806248,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.01 [0.77-1.32],0.926681258222954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.02 [0.73-1.41],0.927058286312862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.01 [0.9-1.13],0.927422488749762,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,0.99 [0.76-1.29],0.927564960941087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.97 [0.53-1.78],0.92756584664006,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RETN,Resistin,Inverse variance weighted,9,0.99 [0.85-1.17],0.929604244761853,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,0.97 [0.47-2.01],0.933579814441193,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.98 [0.64-1.5],0.936214889448054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PLXNB2,Plexin-B2,Inverse variance weighted,27,1 [0.92-1.08],0.936320209829722,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,1.01 [0.75-1.37],0.941051847025508,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLK6,Kallikrein-6,Inverse variance weighted,4,1.01 [0.7-1.46],0.941405160387707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC3B,Tetranectin,Inverse variance weighted,7,0.99 [0.7-1.39],0.942920255411874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,THBD,Thrombomodulin,Inverse variance weighted,5,0.99 [0.65-1.49],0.943809742413259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,0.99 [0.68-1.43],0.944276336939841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCG2,Secretogranin-2,Wald ratio,1,1.05 [0.22-5.04],0.948854916694808,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.02 [0.61-1.69],0.949237602105427,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTN,Pleiotrophin,Inverse variance weighted,4,1.02 [0.55-1.9],0.949491564523801,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.99 [0.84-1.18],0.951441283251337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.99 [0.78-1.26],0.954455219142897,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CHGA,Chromogranin-A,Inverse variance weighted,3,0.99 [0.68-1.44],0.955836765446713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1 [0.87-1.16],0.956833372420275,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.97 [0.33-2.89],0.957813126464979,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,1.04 [0.21-5.08],0.960164608121394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,1 [0.85-1.19],0.960314876590142,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.02 [0.51-2.02],0.961769375532222,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,1 [0.83-1.21],0.963873172121569,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1 [0.86-1.17],0.965439748238565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.04 [0.16-6.69],0.96568708781461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,1 [0.91-1.1],0.967254746486091,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.01 [0.72-1.4],0.968813308700923,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VIT,Vitrin,Inverse variance weighted,25,1 [0.89-1.12],0.968833842700542,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,0.99 [0.72-1.36],0.969533464552206,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,1.01 [0.74-1.36],0.970311144458034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AMBP,Protein AMBP,Inverse variance weighted,3,0.99 [0.61-1.62],0.971159073684685,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1 [0.81-1.24],0.973150881960355,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1 [0.85-1.18],0.973774563245388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1 [0.78-1.29],0.975645358933996,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1 [0.91-1.1],0.976066607956518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1 [0.8-1.25],0.977185584001727,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1 [0.8-1.25],0.983233873986244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1 [0.75-1.34],0.983429511804392,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1 [0.76-1.3],0.984557157425157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1 [0.64-1.57],0.985322952703758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1 [0.91-1.09],0.985566521438836,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MARCO,Macrophage receptor MARCO,Inverse variance weighted,10,1 [0.79-1.27],0.987974551535848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1 [0.74-1.34],0.992831373041156,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,1 [0.65-1.54],0.992909736599436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1 [0.4-2.52],0.997896483442035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LGALS4,Galectin-4,Inverse variance weighted,4,1 [0.6-1.66],0.999058524800835,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CDH17,Cadherin-17,Inverse variance weighted,31,0.8 [0.71-0.91],0.000934130828931874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,4.5 [1.82-11.11],0.00110206172887686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,19,0.77 [0.65-0.9],0.0015075116393588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,9,0.61 [0.45-0.83],0.00164479755214106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HEPH,Hephaestin,Inverse variance weighted,6,0.59 [0.42-0.82],0.00190972375312233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RSPO1,R-spondin-1,Inverse variance weighted,8,0.52 [0.34-0.8],0.00257915740037543,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,0.79 [0.67-0.92],0.00308643950006488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,1.62 [1.17-2.24],0.00354041611848138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.69 [0.54-0.89],0.00468552290369605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SERPINB8,Serpin B8,Inverse variance weighted,29,0.89 [0.81-0.97],0.00648125910160584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,2.49 [1.28-4.83],0.00712650901526663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SELE,E-selectin,Inverse variance weighted,20,0.83 [0.73-0.96],0.0090914324168315,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,38,1.29 [1.06-1.57],0.0109389921028039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PPY,Pancreatic prohormone,Inverse variance weighted,23,0.74 [0.59-0.93],0.0110985723810439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.37 [1.07-1.77],0.0140928621427077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,0.83 [0.72-0.96],0.0141353053415633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ARHGEF5,Rho guanine nucleotide exchange factor 5,Inverse variance weighted,2,0.23 [0.07-0.74],0.0144163422499217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC3B,Tetranectin,Inverse variance weighted,2,5.26 [1.38-20.1],0.0151114278849758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,1.17 [1.03-1.34],0.0153905113189054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ITGB6,Integrin beta-6,Inverse variance weighted,16,0.68 [0.5-0.93],0.0166356131431152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.66 [0.47-0.93],0.0168530601735206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.67 [1.09-2.57],0.0179946076629236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GPC1,Glypican-1,Inverse variance weighted,28,1.25 [1.04-1.5],0.0180403957050573,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,1.14 [1.02-1.28],0.0182625749420976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.16 [0.03-0.74],0.0190858855318028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.68 [0.49-0.94],0.0200954976343003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,REN,Renin,Inverse variance weighted,8,1.88 [1.1-3.2],0.0204184722844198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLK10,Kallikrein-10,Wald ratio,1,0.1 [0.01-0.72],0.0216847528914117,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.43 [0.21-0.89],0.0224753467788948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FABP6,Gastrotropin,Inverse variance weighted,4,0.39 [0.17-0.88],0.0234731241595135,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,0.51 [0.29-0.91],0.0236472802689404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.08 [0.01-0.72],0.0237284931403457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,0.58 [0.36-0.93],0.0238081981852343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.7 [0.51-0.95],0.0241680529564416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CSTB,Cystatin-B,Inverse variance weighted,23,0.83 [0.7-0.98],0.0243732886198015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,XCL1,Lymphotactin,Inverse variance weighted,15,0.61 [0.39-0.94],0.0259538084613722,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.87 [0.77-0.98],0.0265206596178655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.22 [0.06-0.84],0.0269823195702047,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",Inverse variance weighted,17,1.27 [1.03-1.57],0.0279247424764552,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,2.22 [1.08-4.57],0.0309368065909362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,0.82 [0.68-0.98],0.0336112776801669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HEG1,Protein HEG homolog 1,Inverse variance weighted,14,0.66 [0.45-0.98],0.0369688343742002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IFNL1,Interferon lambda-1,Inverse variance weighted,8,1.54 [1.02-2.31],0.0389104138658458,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,22,0.76 [0.58-0.99],0.0420669808539822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.71 [1.02-2.88],0.0423507807092428,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.15 [1-1.31],0.0442546452129766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,0.33 [0.11-0.98],0.0457909788433067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTBS,Di-N-acetylchitobiase,Inverse variance weighted,20,0.81 [0.65-1],0.0471300880066823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NOMO1,Nodal modulator 1,Inverse variance weighted,24,0.85 [0.73-1],0.0485921072182332,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,3,0.45 [0.2-1],0.0508249512351303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,6.37 [0.99-41.03],0.0514060204212767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,0.69 [0.48-1.01],0.0533257082278983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL22,Interleukin-22,Inverse variance weighted,4,0.4 [0.15-1.01],0.0533312611492961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,0.68 [0.45-1.01],0.0560695889034654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.74 [0.54-1.01],0.0575797696870359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,1.14 [1-1.3],0.0581013502307306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,1.5 [0.98-2.28],0.0591325047789367,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.65 [0.41-1.02],0.0594441319651143,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PYDC1,Pyrin domain-containing protein 1,Inverse variance weighted,60,0.9 [0.8-1],0.0600539109454958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,1.74 [0.98-3.09],0.0601780200663774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.61 [0.36-1.02],0.0605983033569062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.84 [0.97-3.51],0.0625452362808086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,21,1.19 [0.99-1.42],0.0644499688495874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,23,1.23 [0.99-1.54],0.0653940180772093,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,0.84 [0.7-1.01],0.0672450565223715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,2.38 [0.93-6.07],0.0701079514649031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,0.52 [0.26-1.06],0.0732305550737355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.32 [0.97-1.78],0.0755587660361377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.68 [0.44-1.04],0.0784063064979219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.4 [0.14-1.12],0.0809640285845772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.58 [0.94-2.65],0.0814592760157743,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PXN,Paxillin,Inverse variance weighted,7,0.62 [0.36-1.06],0.0815322169850753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,0.63 [0.38-1.06],0.0840072251263695,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.3 [0.96-1.76],0.0844668653993328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RETN,Resistin,Inverse variance weighted,19,0.76 [0.56-1.04],0.0870230560917627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,STC2,Stanniocalcin-2,Inverse variance weighted,10,0.67 [0.43-1.06],0.0872906383289539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.32 [0.96-1.82],0.087557692713762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.21 [0.97-1.5],0.090053070454249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,1.28 [0.96-1.71],0.0911243802477217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,0.92 [0.83-1.02],0.0966838392787048,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.58 [0.3-1.11],0.0981996012773855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,0.59 [0.32-1.1],0.0990766432916081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DSC2,Desmocollin-2,Inverse variance weighted,16,0.83 [0.67-1.04],0.0996536496358583,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,1.77 [0.89-3.5],0.100779362461456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CALB1,Calbindin,Inverse variance weighted,9,0.7 [0.45-1.08],0.102706425310525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.6 [0.91-2.84],0.104559979909105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.79 [0.59-1.05],0.105448121114865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.15 [0.97-1.36],0.105508150360071,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LBR,Delta(14)-sterol reductase LBR,Inverse variance weighted,2,0.39 [0.12-1.23],0.107653613403361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,4.55 [0.72-29.01],0.108481687568588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,0.71 [0.47-1.08],0.109149021792567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DLK1,Protein delta homolog 1,Inverse variance weighted,10,1.5 [0.91-2.46],0.109783935751624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CFC1,Cryptic protein,Inverse variance weighted,11,0.7 [0.45-1.09],0.110636264723551,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,0.71 [0.46-1.08],0.11081258666442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL19,Interleukin-19,Inverse variance weighted,10,1.24 [0.95-1.61],0.110995125281809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,XG,Glycoprotein Xg,Inverse variance weighted,2,0.35 [0.1-1.3],0.117439545750539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,0.73 [0.5-1.08],0.118134162017335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,12,1.48 [0.9-2.42],0.118287071321204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.6 [0.88-2.91],0.120354651757609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,0.93 [0.85-1.02],0.123214744142062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.89 [0.77-1.03],0.123536130243252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.58 [0.88-2.85],0.126413212499983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.65 [0.38-1.13],0.127760873056838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CA3,Carbonic anhydrase 3,Inverse variance weighted,10,0.71 [0.45-1.11],0.12817254560698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.73 [0.49-1.09],0.128522625050024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.42 [0.9-2.24],0.12876841647371,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTPRR,Receptor-type tyrosine-protein phosphatase R,Wald ratio,1,2.41 [0.77-7.52],0.129499392018387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,1.65 [0.86-3.14],0.130755253126575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SNCG,Gamma-synuclein,Inverse variance weighted,47,1.09 [0.97-1.22],0.132191105381724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL18,Interleukin-18,Inverse variance weighted,26,1.16 [0.96-1.4],0.13306500816418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPINK6,Serine protease inhibitor Kazal-type 6,Wald ratio,1,3.77 [0.66-21.43],0.134714451004241,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,6,0.72 [0.47-1.11],0.138472819577635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,1.11 [0.97-1.27],0.140019366922483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,1.27 [0.93-1.73],0.140181046581841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OPTC,Opticin,Inverse variance weighted,16,1.29 [0.92-1.81],0.141938753540176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FBLN2,Fibulin-2,Inverse variance weighted,6,1.51 [0.87-2.63],0.145482313962209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.75 [0.82-3.7],0.147034357418588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.36 [0.09-1.44],0.148555028979323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.63 [0.33-1.18],0.148691007714744,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,6,0.56 [0.25-1.24],0.152244874306595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.89 [0.75-1.05],0.153002057313875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GRP,Gastrin-releasing peptide,Inverse variance weighted,21,1.11 [0.96-1.28],0.15417163015755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.4 [0.88-2.21],0.154555660182319,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.43 [0.14-1.38],0.156169956357417,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.65 [0.35-1.19],0.159842469671097,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.78 [0.55-1.11],0.160829823842225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,3.6 [0.59-22.04],0.166244376426394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CDH1,Cadherin-1,Inverse variance weighted,16,0.81 [0.61-1.09],0.166312714157613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,1.33 [0.89-1.98],0.170451717174092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,1.22 [0.92-1.61],0.172990355413739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.15 [0.94-1.42],0.173865170777997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,1.34 [0.88-2.04],0.175268061709953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,1.28 [0.89-1.83],0.176877554377919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD59,CD59 glycoprotein,Inverse variance weighted,4,2.02 [0.72-5.69],0.182687278150576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,1.27 [0.89-1.81],0.183217434864359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,2.08 [0.71-6.16],0.184065744119333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CPB1,Carboxypeptidase B,Inverse variance weighted,18,1.21 [0.91-1.62],0.184353411373493,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FCRLB,Fc receptor-like B,Inverse variance weighted,10,1.35 [0.86-2.1],0.186877975049757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,2.91 [0.59-14.3],0.189570265366182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.65 [0.34-1.24],0.190827299701191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,JCHAIN,Immunoglobulin J chain,Inverse variance weighted,24,0.82 [0.61-1.1],0.192475626972386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,0.95 [0.89-1.02],0.193314869617504,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLK14,Kallikrein-14,Inverse variance weighted,15,1.31 [0.87-1.96],0.196692960147478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP10,Stromelysin-2,Wald ratio,1,0.29 [0.04-1.9],0.197288381562001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PI3,Elafin,Inverse variance weighted,18,1.14 [0.93-1.4],0.197648522877503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RTBDN,Retbindin,Inverse variance weighted,2,1.91 [0.71-5.09],0.197976579892859,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.12 [0.94-1.33],0.198152776592111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,POF1B,Protein POF1B,Inverse variance weighted,4,0.65 [0.34-1.25],0.200004889538385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.36 [0.85-2.16],0.200205635835101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GLA,Alpha-galactosidase A,Inverse variance weighted,2,0.47 [0.14-1.5],0.200334791357693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.19 [0.91-1.54],0.201596559075164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DCN,Decorin,Inverse variance weighted,2,0.43 [0.12-1.57],0.201874037715904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,0.92 [0.82-1.04],0.207710875235632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.56 [0.22-1.39],0.210475554119184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SDC1,Syndecan-1,Inverse variance weighted,12,0.79 [0.54-1.15],0.210634582242799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,50,1.15 [0.92-1.43],0.211879370804843,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DNM3,Dynamin-3,Inverse variance weighted,11,1.19 [0.9-1.58],0.212620020684536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CST5,Cystatin-D,Inverse variance weighted,29,1.22 [0.89-1.67],0.212926399652166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.81 [0.59-1.13],0.214872346298272,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,0.88 [0.73-1.08],0.217469632557223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SEMA7A,Semaphorin-7A,Inverse variance weighted,20,0.84 [0.64-1.11],0.219352367558822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,0.48 [0.15-1.54],0.220395004384851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.06 [0.97-1.16],0.22155210194266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MME,Neprilysin,Inverse variance weighted,46,1.1 [0.94-1.28],0.221580637372495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,7,1.46 [0.8-2.67],0.221599085093262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SEPTIN8,Septin-8,Inverse variance weighted,4,0.66 [0.33-1.29],0.222254352807692,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,79,0.95 [0.86-1.03],0.22236433597023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PCDH17,Protocadherin-17,Inverse variance weighted,44,0.91 [0.78-1.06],0.223143037039033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OGFR,Opioid growth factor receptor,Inverse variance weighted,2,1.73 [0.71-4.25],0.227646780401167,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,9,1.26 [0.87-1.83],0.229878394162839,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.83 [0.61-1.12],0.230090634198097,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.29 [0.85-1.97],0.231699533675889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DRAXIN,Draxin,Inverse variance weighted,25,1.17 [0.9-1.52],0.2349230110236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NXPH3,Neurexophilin-3,Inverse variance weighted,19,1.13 [0.92-1.37],0.235675653843322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,2.07 [0.62-6.89],0.23648461996996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP7,Matrilysin,Wald ratio,1,1.51 [0.76-2.97],0.237070130944227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,2.13 [0.61-7.45],0.238403325918625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL17C,Interleukin-17C,Inverse variance weighted,5,1.55 [0.75-3.19],0.239806767391053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,0.86 [0.66-1.11],0.241836997436189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MYL3,Myosin light chain 3,Inverse variance weighted,13,1.28 [0.85-1.93],0.242337549871909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,4.44 [0.36-54.71],0.244144902255382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FAM3D,Protein FAM3D,Inverse variance weighted,38,0.89 [0.74-1.08],0.245184259688646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,THBD,Thrombomodulin,Inverse variance weighted,11,0.82 [0.59-1.15],0.249949332082338,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.08 [0.95-1.23],0.2522949339234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,1.34 [0.81-2.23],0.253749670698459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL8,Interleukin-8,Inverse variance weighted,8,1.28 [0.84-1.94],0.253958878854991,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.4 [0.08-1.94],0.255379718480378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,1.38 [0.79-2.38],0.255450185728777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PALM,Paralemmin-1,Inverse variance weighted,4,1.5 [0.74-3.04],0.258186991042661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COLEC12,Collectin-12,Inverse variance weighted,3,1.82 [0.65-5.12],0.258192390032726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.32 [0.81-2.15],0.26089961612043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.86 [0.63-5.5],0.26100431714688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,2.66 [0.48-14.8],0.263837090262325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,0.52 [0.17-1.64],0.264851243932555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,0.51 [0.16-1.65],0.26508925961724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,1.28 [0.83-1.97],0.265967792678488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.44 [0.76-2.74],0.266640720530014,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EFNB2,Ephrin-B2,Wald ratio,1,0.76 [0.47-1.23],0.27022458155247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CFD,Complement factor D,Wald ratio,1,2.39 [0.51-11.3],0.270357616223401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTSE,Cathepsin E,Inverse variance weighted,8,0.68 [0.34-1.36],0.271969397168455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD48,CD48 antigen,Inverse variance weighted,14,0.79 [0.52-1.2],0.275195307859751,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,43,0.96 [0.9-1.03],0.275710937679128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP8,Neutrophil collagenase,Inverse variance weighted,10,0.82 [0.56-1.18],0.278773177101834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.61 [0.25-1.49],0.280300266022289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.51 [0.15-1.73],0.281303743284677,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL14,C-X-C motif chemokine 14,Inverse variance weighted,4,0.68 [0.33-1.38],0.284263687427075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,1.07 [0.94-1.21],0.285574985417554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.93 [0.58-6.46],0.286669383445882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.16 [0.88-1.53],0.288986206463705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.72 [0.4-1.32],0.289024886963637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.48 [0.12-1.88],0.289765210286776,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTN,Pleiotrophin,Inverse variance weighted,3,1.54 [0.69-3.42],0.28985276091258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,0.52 [0.15-1.76],0.291777270375704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.89 [0.71-1.11],0.293297319448955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.92 [0.79-1.07],0.293501766156921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MILR1,Allergin-1,Inverse variance weighted,43,1.05 [0.96-1.14],0.295322672175066,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,0.88 [0.68-1.12],0.297849402325772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP3,Stromelysin-1,Inverse variance weighted,4,0.43 [0.09-2.11],0.298327715692141,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,3,0.72 [0.39-1.34],0.298834752788945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.34 [0.77-2.33],0.299646195902276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,1.35 [0.77-2.36],0.300123073813691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP13,Collagenase 3,Wald ratio,1,2.34 [0.47-11.65],0.30111269672605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BSG,Basigin,Inverse variance weighted,6,1.46 [0.71-2.98],0.304426008143046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,0.7 [0.36-1.38],0.30556807863311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.25 [0.82-1.91],0.305795805915046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,WFDC1,WAP four-disulfide core domain protein 1,Wald ratio,1,2.58 [0.42-15.94],0.307278115531001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.23 [0.83-1.81],0.308406236439891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,0.85 [0.61-1.17],0.309275262664725,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FOLR2,Folate receptor beta,Inverse variance weighted,14,1.2 [0.84-1.71],0.312514940326822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,UMOD,Uromodulin,Inverse variance weighted,34,1.15 [0.88-1.52],0.312899378415364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OSM,Oncostatin-M,Inverse variance weighted,6,0.79 [0.5-1.25],0.31464219267307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.31 [0.78-2.2],0.314643018031457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,0.75 [0.43-1.32],0.315409275617569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,1.2 [0.84-1.7],0.316844306884869,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RGMB,RGM domain family member B,Inverse variance weighted,5,0.69 [0.33-1.44],0.322331794578795,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.84 [0.59-1.19],0.323735426313382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,16,0.85 [0.61-1.18],0.331265975628043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,0.9 [0.74-1.11],0.331829847523606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,1.24 [0.8-1.92],0.334671884319653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.92 [0.77-1.09],0.338506594962528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DSG2,Desmoglein-2,Inverse variance weighted,22,0.89 [0.71-1.13],0.340292734048058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,0.79 [0.48-1.29],0.341015203674234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.52 [0.64-3.62],0.34193467907745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD8A,T-cell surface glycoprotein CD8 alpha chain,Inverse variance weighted,4,0.6 [0.21-1.73],0.34330658703959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SBSN,Suprabasin,Inverse variance weighted,10,0.77 [0.45-1.32],0.343602906004635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,22,0.9 [0.72-1.12],0.34608168394009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRELP,Prolargin,Inverse variance weighted,5,1.68 [0.57-4.94],0.348117057759977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,1.1 [0.9-1.34],0.350386437671186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.13 [0.87-1.47],0.351333717779464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLK4,Kallikrein-4,Inverse variance weighted,5,1.55 [0.61-3.93],0.352297696054795,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRSS8,Prostasin,Inverse variance weighted,14,0.84 [0.58-1.21],0.352713933760841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.82 [0.55-1.24],0.35394243981375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RGMA,Repulsive guidance molecule A,Inverse variance weighted,35,1.09 [0.91-1.31],0.356708840868308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.84 [0.57-1.22],0.359862194635885,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.84 [0.58-1.22],0.363653198967023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",Inverse variance weighted,18,0.88 [0.67-1.16],0.36824536792069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,30,0.87 [0.64-1.18],0.374462247864518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.76 [0.42-1.39],0.374661278531,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,17,0.86 [0.62-1.19],0.375195747946565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,0.77 [0.43-1.37],0.376187096878217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EGLN1,Egl nine homolog 1,Wald ratio,1,2.19 [0.38-12.45],0.377179575973646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.67 [0.27-1.64],0.379092260790836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,1.08 [0.91-1.27],0.385812624243657,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,0.71 [0.33-1.53],0.3860708664875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,1.29 [0.73-2.29],0.386105365329857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.72 [0.35-1.5],0.386147282853206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,17,1.13 [0.85-1.51],0.389497417637508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.51 [0.59-3.89],0.389571423847037,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.84 [0.56-1.26],0.393185573729141,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1.08 [0.91-1.28],0.394336390172582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,0.84 [0.57-1.25],0.394450614734089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.12 [0.86-1.47],0.394589227831507,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRSS27,Serine protease 27,Inverse variance weighted,47,1.06 [0.93-1.22],0.395915959615671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MSLN,Mesothelin,Inverse variance weighted,11,0.77 [0.43-1.4],0.396803835587573,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OGN,Mimecan,Inverse variance weighted,37,1.07 [0.92-1.24],0.397090860532639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,APOA4,Apolipoprotein A-IV,Inverse variance weighted,4,1.62 [0.53-4.96],0.398651621357265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.86 [0.61-1.22],0.405622071195415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ANGPTL2,Angiopoietin-related protein 2,Inverse variance weighted,12,0.86 [0.6-1.23],0.407707585720966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD164,Sialomucin core protein 24,Inverse variance weighted,8,0.74 [0.37-1.51],0.409310998479441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.87 [0.64-1.2],0.410578309088959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PYY,Peptide YY,Inverse variance weighted,16,0.91 [0.72-1.14],0.412099747466064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GRN,Progranulin,Inverse variance weighted,46,0.95 [0.84-1.08],0.412447638272635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,4,0.82 [0.51-1.32],0.414891503046626,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,1.24 [0.74-2.08],0.419357999300515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CX3CL1,Fractalkine,Inverse variance weighted,12,1.2 [0.77-1.87],0.419495139197266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,0.8 [0.46-1.38],0.419708624100211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NFASC,Neurofascin,Inverse variance weighted,6,0.75 [0.37-1.51],0.420795993335116,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCG2,Secretogranin-2,Inverse variance weighted,2,1.46 [0.58-3.71],0.421593130638119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.25 [0.73-2.14],0.424051778152209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HJV,Hemojuvelin,Inverse variance weighted,2,1.67 [0.47-5.89],0.425272546955649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.23 [0.74-2.05],0.427840248368309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,0.92 [0.74-1.14],0.428631898475188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,1.27 [0.7-2.31],0.428635108095704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,9,0.75 [0.36-1.54],0.428946370227342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.28 [0.69-2.39],0.433540587431232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,0.74 [0.35-1.57],0.433612111554111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,17,1.11 [0.86-1.43],0.435259440240308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.94 [0.79-1.1],0.436121745677598,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.07 [0.9-1.27],0.439867969269129,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.37 [0.61-3.05],0.44231041523263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.92 [0.74-1.14],0.443751661302496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,1.19 [0.76-1.86],0.445731767739015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.81 [0.47-1.39],0.449784675748291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.53 [0.1-2.77],0.451166057217069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LEPR,Leptin receptor,Inverse variance weighted,3,1.41 [0.58-3.41],0.451276918264325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.89 [0.66-1.21],0.452014950442942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.82 [0.48-1.39],0.454488495910787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,1.22 [0.73-2.05],0.454795680123618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.41 [0.57-3.5],0.454992714209678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CPM,Carboxypeptidase M,Inverse variance weighted,19,0.86 [0.59-1.27],0.455559714714441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.85 [0.56-1.3],0.455567563016457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Wald ratio,1,0.48 [0.07-3.3],0.457091990774741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.84 [0.52-1.34],0.459296031503636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,11,0.84 [0.54-1.32],0.460092935271202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.85 [0.54-1.32],0.462898575322764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL15,Interleukin-15,Inverse variance weighted,35,0.92 [0.73-1.16],0.463363380715436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VIT,Vitrin,Inverse variance weighted,10,1.2 [0.74-1.96],0.464770729315786,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.12 [0.82-1.52],0.469584644799891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,0.88 [0.63-1.23],0.469685085279172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.29 [0.64-2.59],0.470724364582579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.32 [0.62-2.79],0.471500537648987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,0.79 [0.42-1.49],0.471600318224499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTSL,Cathepsin L1,Inverse variance weighted,29,1.1 [0.85-1.42],0.474200769189629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BRK1,Protein BRICK1,Inverse variance weighted,10,0.86 [0.57-1.3],0.474278884494013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,10,0.83 [0.51-1.37],0.475672794566043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.2 [0.72-1.99],0.478799502932583,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.77 [0.36-8.58],0.478844127604697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,0.92 [0.74-1.15],0.479747048782417,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,0.8 [0.43-1.49],0.48448066080381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.14 [0.78-1.67],0.484929908426397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.2 [0.72-2.01],0.485971237803258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.23 [0.69-2.2],0.487776263072246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NPTXR,Neuronal pentraxin receptor,Inverse variance weighted,10,0.81 [0.44-1.49],0.487814994859933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CDH2,Cadherin-2,Inverse variance weighted,21,1.12 [0.81-1.56],0.488118644311587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL17D,Interleukin-17D,Inverse variance weighted,2,1.65 [0.4-6.76],0.489036491232521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLK6,Kallikrein-6,Inverse variance weighted,2,1.48 [0.49-4.5],0.489288010137827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,1.13 [0.79-1.61],0.492784741985874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL11,Eotaxin,Inverse variance weighted,11,1.1 [0.84-1.44],0.493509100838712,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,14,1.25 [0.66-2.35],0.494842162080216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.14 [0.79-1.65],0.49505346105286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LGALS4,Galectin-4,Inverse variance weighted,15,0.93 [0.76-1.14],0.49764586353685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.83 [0.49-1.42],0.497954942058847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,C7,Complement component C7,Inverse variance weighted,26,1.05 [0.91-1.23],0.498835086326124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.97 [0.88-1.07],0.501248713320955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.13 [0.8-1.59],0.505899588682101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,1.94 [0.28-13.68],0.506267638800635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DEFB4A_DEFB4B,Beta-defensin 4A,Inverse variance weighted,7,1.2 [0.7-2.03],0.506384188731865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MFGE8,Lactadherin,Inverse variance weighted,15,0.87 [0.59-1.3],0.506516067057488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.18 [0.72-1.92],0.510298686838011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.1 [0.83-1.45],0.510865565590127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,0.85 [0.53-1.37],0.511749377869202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.2 [0.69-2.07],0.513481205802417,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,INHBC,Inhibin beta C chain,Inverse variance weighted,12,1.14 [0.77-1.69],0.514036627360483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.19 [0.71-2],0.514220780913462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.15 [0.76-1.73],0.514602576872305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.95 [0.83-1.1],0.514870127224562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EPO,Erythropoietin,Inverse variance weighted,11,0.91 [0.68-1.21],0.515198189629099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.65 [0.36-7.45],0.518311168277318,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,11,0.89 [0.62-1.27],0.519190206048217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MPO,Myeloperoxidase,Inverse variance weighted,17,1.07 [0.88-1.29],0.520389392094749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,1.05 [0.91-1.2],0.520886706131881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,0.74 [0.29-1.88],0.52120789018525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,0.88 [0.6-1.3],0.523025243271582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.48 [0.45-4.88],0.523119476356922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.71 [0.24-2.05],0.524302455112496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AGRP,Agouti-related protein,Inverse variance weighted,16,1.09 [0.84-1.41],0.525085968238661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IDUA,Alpha-L-iduronidase,Inverse variance weighted,18,1.14 [0.76-1.71],0.52543666931952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VCAN,Versican core protein,Inverse variance weighted,30,0.93 [0.74-1.17],0.526395366445698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LGALS9,Galectin-9,Inverse variance weighted,36,1.06 [0.89-1.25],0.530227408710404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRSS2,Trypsin-2,Inverse variance weighted,17,0.9 [0.64-1.26],0.530791398829983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,0.78 [0.36-1.69],0.531070197896013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.92 [0.7-1.21],0.531653556994782,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RCC1,Regulator of chromosome condensation,Wald ratio,1,0.59 [0.11-3.1],0.532119270282149,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GUCA2A,Guanylin,Inverse variance weighted,7,1.3 [0.57-3],0.532982066438516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,8,1.14 [0.75-1.74],0.534192316269788,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.81 [0.41-1.59],0.53884722363362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.89 [0.62-1.28],0.540395731509747,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.77 [0.33-1.79],0.54054872511411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,0.92 [0.7-1.21],0.544062882050233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LGALS3,Galectin-3,Inverse variance weighted,15,1.12 [0.78-1.61],0.546209981005445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GPR15L,Protein GPR15L,Inverse variance weighted,13,0.93 [0.75-1.17],0.546216450598223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPON1,Spondin-1,Inverse variance weighted,4,1.26 [0.59-2.69],0.548224507425352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,0.78 [0.35-1.76],0.552382548961963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,0.92 [0.7-1.21],0.552423081254773,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NRP2,Neuropilin-2,Inverse variance weighted,14,1.16 [0.72-1.86],0.55484778186101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.18 [0.68-2.04],0.555761336619283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ACP6,Lysophosphatidic acid phosphatase type 6,Inverse variance weighted,13,0.92 [0.7-1.22],0.556078721485589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,1.11 [0.79-1.55],0.556984465580234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CHGA,Chromogranin-A,Inverse variance weighted,5,1.31 [0.53-3.2],0.559121505512823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.19 [0.67-2.11],0.55924821663833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.74 [0.27-2.04],0.559935457885605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,0.92 [0.71-1.21],0.56246908474301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.41 [0.44-4.49],0.562877056251131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,18,1.1 [0.8-1.5],0.563450657482335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,0.88 [0.56-1.38],0.564744706789736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,1.16 [0.69-1.96],0.56495125408278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,0.81 [0.39-1.66],0.564994072788861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,0.81 [0.39-1.68],0.565137641390881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL16,Pro-interleukin-16,Inverse variance weighted,6,0.8 [0.37-1.72],0.565184753489013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,4,1.35 [0.49-3.72],0.566171409078827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,0.77 [0.32-1.87],0.567218364835379,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MDK,Midkine,Inverse variance weighted,14,0.89 [0.61-1.32],0.573023813369634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.87 [0.54-1.41],0.575043664086139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1.32 [0.5-3.51],0.577008646497267,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.08 [0.82-1.44],0.577870696492376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COCH,Cochlin,Inverse variance weighted,21,1.12 [0.76-1.65],0.578530406849175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,3,0.5 [0.04-5.95],0.581277387171381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,0.9 [0.61-1.31],0.581416874110366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PALM2,Paralemmin-2,Inverse variance weighted,9,1.09 [0.8-1.49],0.58282126587424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD83,CD83 antigen,Inverse variance weighted,14,1.14 [0.72-1.81],0.58527939038327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,0.89 [0.59-1.34],0.587568818998931,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.96 [0.84-1.1],0.588069883101349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PGA4,Pepsin A-4,Inverse variance weighted,7,1.17 [0.66-2.07],0.588134847626268,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.34 [0.46-3.93],0.588831298188874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,S100P,Protein S100-P,Inverse variance weighted,4,0.85 [0.48-1.52],0.589274037876431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OCLN,Occludin,Inverse variance weighted,2,1.81 [0.21-15.54],0.589356997388491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,0.88 [0.55-1.4],0.591378446448233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,1.22 [0.59-2.49],0.593362534663011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.83 [0.41-1.67],0.593565334727463,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.12 [0.74-1.71],0.593620132527831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",Wald ratio,1,0.69 [0.17-2.71],0.593690336439766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,14,1.13 [0.73-1.74],0.595397044380916,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,0.92 [0.69-1.24],0.596043230855141,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.85 [0.19-18.04],0.597656650739285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.13 [0.72-1.76],0.597759298661781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.18 [0.63-2.2],0.598860428876892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.2 [0.6-2.4],0.59952510084176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,B2M,Beta-2-microglobulin,Inverse variance weighted,7,0.75 [0.26-2.2],0.600331120182723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.35 [0.44-4.21],0.601004965458406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,6,0.82 [0.39-1.74],0.605951350210989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GCG,Pro-glucagon,Inverse variance weighted,2,0.74 [0.24-2.31],0.607225029536853,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,1.15 [0.68-1.93],0.6101365353585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CAPG,Macrophage-capping protein,Wald ratio,1,0.7 [0.18-2.78],0.610719099332624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,5,0.83 [0.39-1.73],0.610823867352027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PSAP,Prosaposin,Inverse variance weighted,13,1.07 [0.82-1.39],0.610965252450053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,0.97 [0.87-1.08],0.611983180860517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.12 [0.72-1.73],0.612489660567105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.94 [0.73-1.2],0.613618813109072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.07 [0.82-1.41],0.613628859238028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.06 [0.84-1.34],0.614744343356486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LCN15,Lipocalin-15,Inverse variance weighted,22,1.04 [0.9-1.19],0.616322876536761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CA6,Carbonic anhydrase 6,Inverse variance weighted,21,1.1 [0.77-1.57],0.618842717721513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.36 [0.4-4.61],0.619890039691271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Inverse variance weighted,4,0.82 [0.37-1.81],0.620354972619136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1.03 [0.92-1.16],0.621847138325679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.04 [0.89-1.22],0.622152219514606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,F11R,Junctional adhesion molecule A,Inverse variance weighted,3,1.23 [0.54-2.79],0.622961057969023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD276,CD276 antigen,Inverse variance weighted,24,0.94 [0.74-1.2],0.623138681305122,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DPT,Dermatopontin,Inverse variance weighted,4,1.25 [0.51-3.06],0.623636806464256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,0.89 [0.56-1.41],0.623835290208337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.83 [0.4-1.74],0.628085296622506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,40,1.04 [0.88-1.23],0.628710982462069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.92 [0.65-1.3],0.629639863797457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.14 [0.67-1.95],0.630332558946818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AGRN,Agrin,Inverse variance weighted,14,1.1 [0.74-1.63],0.631218758084429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Inverse variance weighted,4,1.44 [0.33-6.33],0.631300189005368,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LPO,Lactoperoxidase,Inverse variance weighted,29,1.04 [0.89-1.2],0.632010278237064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.85 [0.44-1.64],0.632271552370738,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.96 [0.79-1.15],0.632295338492619,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NECTIN2,Nectin-2,Inverse variance weighted,3,0.75 [0.23-2.47],0.632908018209573,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.07 [0.8-1.43],0.633356767427349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNC,Tenascin,Inverse variance weighted,57,1.03 [0.92-1.15],0.635891539500939,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ELN,Elastin,Inverse variance weighted,10,1.13 [0.69-1.84],0.63649311881262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLK13,Kallikrein-13,Inverse variance weighted,11,1.09 [0.75-1.59],0.636922322860423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,1.58 [0.23-10.72],0.637383795540542,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,0.84 [0.39-1.78],0.642255009912282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.9 [0.56-1.43],0.642961352059993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PENK,Proenkephalin-A,Inverse variance weighted,15,1.07 [0.8-1.43],0.643814881826747,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.24 [0.5-3.05],0.64579556553007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,0.92 [0.64-1.32],0.647298484449861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,0.87 [0.49-1.56],0.648083981765436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.19 [0.56-2.56],0.648650961311056,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.82 [0.34-1.96],0.649697344100362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,1.04 [0.89-1.2],0.650466764726412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,1.05 [0.86-1.28],0.651251263285595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NUCB2,Nucleobindin-2,Inverse variance weighted,2,1.31 [0.4-4.25],0.651636691119768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.1 [0.73-1.65],0.651681692093745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,0.88 [0.51-1.53],0.652894986645996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,1.09 [0.75-1.57],0.6536238032506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,0.95 [0.75-1.2],0.654508550209648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,P4HB,Protein disulfide-isomerase,Inverse variance weighted,4,0.84 [0.38-1.83],0.654770168889758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,0.82 [0.35-1.95],0.657597205684955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.94 [0.71-1.25],0.658533857577634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.93 [0.66-1.3],0.658626640049128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,3,0.78 [0.25-2.38],0.660601660949543,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1.04 [0.88-1.23],0.661065432636623,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,0.89 [0.52-1.51],0.661342561596111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PKD2,Polycystin-2,Inverse variance weighted,3,0.68 [0.12-3.8],0.661637392415876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,1.41 [0.3-6.61],0.66232194988792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL6,Interleukin-6,Inverse variance weighted,6,0.93 [0.67-1.29],0.663952758868687,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.06 [0.8-1.41],0.664029893903838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL36G,Interleukin-36 gamma,Wald ratio,1,0.74 [0.19-2.85],0.666463065548802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,1.05 [0.83-1.33],0.666938737088965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.97 [0.87-1.1],0.670340491259213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD93,Complement component C1q receptor,Inverse variance weighted,2,1.23 [0.48-3.17],0.670658058659699,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLAMF6,SLAM family member 6,Inverse variance weighted,2,0.77 [0.23-2.55],0.672813670282412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.06 [0.8-1.41],0.673228809781385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.05 [0.84-1.32],0.675093701924288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,1.11 [0.68-1.83],0.675645400124426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,3,1.28 [0.4-4.06],0.679665831318584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VASN,Vasorin,Inverse variance weighted,5,1.19 [0.52-2.69],0.680542640436626,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD2,T-cell surface antigen CD2,Wald ratio,1,0.6 [0.05-6.9],0.680945803884397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.24 [0.44-3.46],0.682397247483209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.95 [0.76-1.19],0.684406502228304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PLIN1,Perilipin-1,Wald ratio,1,1.38 [0.29-6.53],0.685891700918958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.86 [0.4-1.83],0.688625542157829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.92 [0.63-1.36],0.690917068948466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,0.93 [0.64-1.34],0.69103559367818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CHRDL2,Chordin-like protein 2,Inverse variance weighted,9,0.89 [0.5-1.58],0.691539295712332,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.13 [0.61-2.1],0.692248002036857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.72 [0.14-3.64],0.692338670868878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,0.93 [0.64-1.34],0.692401094364326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.88 [0.48-1.63],0.692425769475211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.77 [0.22-2.75],0.692912840974351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,0.89 [0.5-1.59],0.693435301464696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.85 [0.38-1.89],0.695630448826761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.3 [0.34-4.98],0.697352332940083,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLRF1,Killer cell lectin-like receptor subfamily F member 1,Inverse variance weighted,20,1.07 [0.77-1.48],0.698261119463196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,0.7 [0.12-4.24],0.699134684382929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MATN2,Matrilin-2,Inverse variance weighted,28,0.97 [0.85-1.11],0.699401121450142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,0.96 [0.77-1.19],0.700321022107655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ALCAM,CD166 antigen,Inverse variance weighted,4,0.91 [0.56-1.48],0.702450721625927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,8,1.1 [0.67-1.79],0.704750359855978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.97 [0.82-1.14],0.704798810967994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.87 [0.44-1.75],0.706564122672228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,0.96 [0.76-1.2],0.707184347939281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PKD1,Polycystin-1,Inverse variance weighted,12,0.88 [0.46-1.69],0.707353481395685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Wald ratio,1,1.38 [0.26-7.38],0.707451628060634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCN3,CCN family member 3,Inverse variance weighted,17,1.04 [0.84-1.3],0.707627175442772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCN5,CCN family member 5,Inverse variance weighted,12,0.95 [0.74-1.23],0.707738805303934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.18 [0.5-2.77],0.709835260667903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CST6,Cystatin-M,Inverse variance weighted,26,1.06 [0.78-1.44],0.712211905084459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.97 [0.83-1.13],0.712396804534329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,1.13 [0.58-2.2],0.713144109621406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,1.33 [0.29-6.08],0.717171694857374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,0.96 [0.76-1.21],0.717385662582602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CST7,Cystatin-F,Inverse variance weighted,46,0.97 [0.82-1.14],0.717654731308654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,0.91 [0.54-1.53],0.720655316380097,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,0.98 [0.86-1.11],0.722409054678772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CRLF1,Cytokine receptor-like factor 1,Inverse variance weighted,15,0.93 [0.6-1.42],0.722457836622599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.12 [0.61-2.04],0.72284239022115,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GAST,Gastrin,Inverse variance weighted,9,0.93 [0.62-1.4],0.72383974505537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,1.18 [0.46-3.01],0.725094591451827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,1.06 [0.76-1.47],0.729288133916003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.06 [0.75-1.51],0.729612270753516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.88 [0.42-1.84],0.7305038268912,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTSV,Cathepsin L2,Inverse variance weighted,34,1.03 [0.86-1.25],0.732146524372954,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,13,1.07 [0.71-1.62],0.732712486844388,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,1.23 [0.38-3.95],0.733075685858445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AHNAK2,Protein AHNAK2,Inverse variance weighted,3,0.83 [0.29-2.37],0.734445500654891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL5RA,Interleukin-5 receptor subunit alpha,Inverse variance weighted,38,1.04 [0.83-1.3],0.735470612219496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,6,0.86 [0.35-2.1],0.735567059704449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LEP,Leptin,Inverse variance weighted,4,1.23 [0.36-4.2],0.737980094891541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CDH6,Cadherin-6,Inverse variance weighted,5,1.13 [0.54-2.36],0.739893463174795,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,0.89 [0.44-1.8],0.742190616593508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.12 [0.56-2.26],0.742455624296184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,WNT9A,Protein Wnt-9a,Wald ratio,1,1.41 [0.18-11.24],0.743248598146087,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.17 [0.46-2.97],0.744397232352394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.91 [0.52-1.59],0.744547291579354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.16 [0.46-2.92],0.745514502148264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PVR,Poliovirus receptor,Inverse variance weighted,3,0.84 [0.3-2.37],0.74559457866555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD302,CD302 antigen,Inverse variance weighted,11,1.06 [0.74-1.51],0.745905606916747,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.91 [0.51-1.63],0.74645998881307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.94 [0.62-1.4],0.746869246841321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,3,1.43 [0.16-12.39],0.747342815924201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,50,1.03 [0.86-1.23],0.747787162572076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.91 [0.52-1.61],0.749301757932178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.92 [0.56-1.51],0.750295350925226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,1.05 [0.78-1.41],0.750668724371508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLK8,Kallikrein-8,Inverse variance weighted,5,0.9 [0.46-1.76],0.758057393624924,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,21,1.03 [0.85-1.24],0.760936834068753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,F9,Coagulation factor IX,Inverse variance weighted,3,0.86 [0.32-2.29],0.762472949096213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.8 [0.19-3.39],0.762697221108132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,F3,Tissue factor,Inverse variance weighted,13,0.93 [0.59-1.46],0.763229061422374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LAYN,Layilin,Inverse variance weighted,3,1.17 [0.42-3.24],0.763422635991927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,1.04 [0.81-1.33],0.765206812390558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.14 [0.47-2.76],0.766378832386877,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,1.03 [0.85-1.25],0.769676169215967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,7,0.91 [0.48-1.72],0.769996584937045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,10,0.93 [0.59-1.48],0.772250661676463,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.87 [0.33-2.26],0.772421923593427,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PCDH7,Protocadherin-7,Inverse variance weighted,3,1.14 [0.46-2.82],0.774787002521661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,22,0.96 [0.7-1.31],0.778063458317831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.78 [0.14-4.25],0.778238609342611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.11 [0.54-2.28],0.778615856332982,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MB,Myoglobin,Inverse variance weighted,9,1.08 [0.62-1.9],0.779415069390592,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TMPRSS11D,Transmembrane protease serine 11D,Wald ratio,1,1.26 [0.25-6.47],0.781808592648579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,0.88 [0.37-2.12],0.781837167335392,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.11 [0.53-2.31],0.781935448837643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCG3,Secretogranin-3,Inverse variance weighted,16,0.94 [0.62-1.43],0.785040074401979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,0.93 [0.53-1.61],0.786437100266433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PPL,Periplakin,Inverse variance weighted,2,0.88 [0.33-2.31],0.787818411411773,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCGB1A1,Uteroglobin,Inverse variance weighted,38,0.96 [0.74-1.25],0.788307935271061,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",Wald ratio,1,0.7 [0.05-9.74],0.789434261776417,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.08 [0.6-1.96],0.791536236058089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SLAMF7,SLAM family member 7,Inverse variance weighted,16,1.04 [0.76-1.42],0.79185223735144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.8 [0.15-4.2],0.792345370441565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.87 [0.31-2.46],0.793709116723513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.92 [0.48-1.74],0.794515568560475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GABARAP,Gamma-aminobutyric acid receptor-associated protein,Inverse variance weighted,4,0.86 [0.28-2.63],0.797959047244892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.92 [0.5-1.71],0.798420463784971,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ANG,Angiogenin,Inverse variance weighted,8,0.89 [0.37-2.14],0.800615226621369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTP4A3,Protein tyrosine phosphatase type IVA 3,Inverse variance weighted,6,1.04 [0.77-1.41],0.800869834209351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,0.94 [0.58-1.52],0.801825437469334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,6,0.87 [0.28-2.66],0.804778434574577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,0.98 [0.86-1.13],0.805776651433077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,0.96 [0.72-1.29],0.806476844471347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CALCA,Calcitonin,Inverse variance weighted,13,0.94 [0.59-1.51],0.807408352637995,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LMNB2,Lamin-B2,Inverse variance weighted,8,1.07 [0.62-1.86],0.807552421440481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MUC13,Mucin-13,Inverse variance weighted,3,0.88 [0.32-2.46],0.81184004283451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LAMB1,Laminin subunit beta-1,Inverse variance weighted,21,0.97 [0.75-1.25],0.812391094791184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CST3,Cystatin-C,Inverse variance weighted,3,0.89 [0.33-2.41],0.814204924129586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,1.07 [0.62-1.83],0.814771613715731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.87 [0.26-2.89],0.815687016629675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,0.97 [0.77-1.23],0.81586578996198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.23 [0.21-7.07],0.816844210728123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD70,CD70 antigen,Inverse variance weighted,11,1.03 [0.78-1.37],0.820433089582283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.09 [0.53-2.23],0.820896819378178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.03 [0.82-1.29],0.823635166586547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,0.98 [0.85-1.13],0.823654217180868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCN4,CCN family member 4,Inverse variance weighted,29,1.02 [0.87-1.2],0.823984057144359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTSS,Cathepsin S,Inverse variance weighted,7,0.94 [0.55-1.61],0.82417077602971,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.06 [0.65-1.71],0.824702036557929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.07 [0.59-1.93],0.82509167482426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DSG3,Desmoglein-3,Inverse variance weighted,27,1.02 [0.84-1.24],0.82566858425276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.79 [0.1-6.24],0.826652481112361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,27,1.03 [0.8-1.32],0.830746905746835,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CRH,Corticoliberin,Inverse variance weighted,55,1.02 [0.88-1.18],0.831723240283821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CYTL1,Cytokine-like protein 1,Inverse variance weighted,3,0.89 [0.31-2.57],0.832940998131437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,1.2 [0.22-6.6],0.833474357375728,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.06 [0.59-1.92],0.833659264395244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,Wald ratio,1,1.24 [0.17-8.97],0.834136965983456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD160,CD160 antigen,Inverse variance weighted,24,1.03 [0.77-1.38],0.835214898584639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,1.02 [0.85-1.22],0.836863207167326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,1.02 [0.85-1.21],0.838881376955751,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.09 [0.48-2.49],0.840763106803974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,THBS2,Thrombospondin-2,Inverse variance weighted,15,1.03 [0.76-1.41],0.841818099626701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,UNC5D,Netrin receptor UNC5D,Wald ratio,1,0.81 [0.11-6.18],0.842480634558784,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.1 [0.41-2.96],0.842961654128707,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AGR3,Anterior gradient protein 3,Inverse variance weighted,5,1.08 [0.49-2.41],0.844651479951353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,Inverse variance weighted,2,0.86 [0.19-3.93],0.844777078938762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NECTIN4,Nectin-4,Inverse variance weighted,4,0.92 [0.39-2.14],0.845032847117197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,1.08 [0.5-2.33],0.845260683654089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.85 [0.15-4.7],0.850405680391022,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,0.94 [0.51-1.76],0.853670019249617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,1.03 [0.72-1.49],0.855399153119324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,0.92 [0.4-2.16],0.855815211984647,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD27,CD27 antigen,Inverse variance weighted,9,1.06 [0.56-2.02],0.856617346555643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.97 [0.71-1.33],0.856809538023887,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.99 [0.85-1.14],0.85722338619076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.02 [0.78-1.34],0.857852109522596,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.93 [0.43-2.04],0.86106023995615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL6R,Interleukin-6 receptor subunit alpha,Inverse variance weighted,7,1.05 [0.59-1.86],0.863947556219769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,0.99 [0.83-1.16],0.864336250830594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.04 [0.64-1.7],0.867274305909769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.06 [0.54-2.09],0.870393823043347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.04 [0.66-1.64],0.871289308902658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.94 [0.42-2.11],0.872021404842642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP1,Interstitial collagenase,Inverse variance weighted,14,1.03 [0.72-1.46],0.873681011145148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRTN3,Myeloblastin,Inverse variance weighted,20,0.98 [0.71-1.33],0.874021269703423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.97 [0.66-1.43],0.874776359158029,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.88 [0.19-4.18],0.875203284547303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,0.97 [0.67-1.41],0.875746510528678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IMMT,MICOS complex subunit MIC60,Wald ratio,1,1.1 [0.31-3.9],0.879608835210977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,0.98 [0.78-1.23],0.880847319080497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PCDH1,Protocadherin-1,Inverse variance weighted,4,1.06 [0.5-2.24],0.881829479499193,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CPA1,Carboxypeptidase A1,Inverse variance weighted,26,0.98 [0.76-1.26],0.881860000758023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ITGA5,Integrin alpha-5,Inverse variance weighted,18,1.02 [0.75-1.39],0.883506387913427,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.09 [0.34-3.46],0.88356095752828,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.96 [0.59-1.58],0.884634643151176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,21,1.02 [0.75-1.39],0.884821118198313,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.02 [0.77-1.34],0.886045443258192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.03 [0.65-1.65],0.886377066134499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,0.96 [0.58-1.6],0.887448984179532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CHGB,Secretogranin-1,Inverse variance weighted,7,0.97 [0.63-1.5],0.89354014123067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPARCL1,SPARC-like protein 1,Inverse variance weighted,21,1.02 [0.8-1.3],0.893797345936017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.01 [0.87-1.17],0.895366520463921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.93 [0.3-2.85],0.896336725481255,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.95 [0.44-2.04],0.896443191880936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.06 [0.45-2.49],0.897313802330017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,1.04 [0.6-1.79],0.899365723691932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.94 [0.38-2.37],0.899853319302753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,0.93 [0.31-2.82],0.900481384036725,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,0.98 [0.7-1.37],0.903483038870374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,2,0.95 [0.38-2.36],0.904152066922003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AMBP,Protein AMBP,Inverse variance weighted,5,0.97 [0.62-1.52],0.905220656729382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.04 [0.54-2],0.905748663860854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CD99,CD99 antigen,Inverse variance weighted,4,1.04 [0.57-1.9],0.906583628275078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.96 [0.46-1.98],0.90773649175634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,1.04 [0.56-1.92],0.911496395932196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.94 [0.3-2.9],0.913470068368369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTSO,Cathepsin O,Inverse variance weighted,19,1.01 [0.82-1.25],0.914165966662307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.97 [0.54-1.75],0.914951384961164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.01 [0.81-1.27],0.915753079981149,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.01 [0.82-1.24],0.915902443813473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HMOX2,Heme oxygenase 2,Inverse variance weighted,3,1.04 [0.49-2.2],0.916733531125033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.96 [0.48-1.93],0.919121386339451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LUZP2,Leucine zipper protein 2,Wald ratio,1,0.91 [0.14-5.7],0.919310498882906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.96 [0.43-2.16],0.91938048023593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCGB3A1,Secretoglobin family 3A member 1,Inverse variance weighted,26,1.01 [0.84-1.22],0.919640301341155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CDH3,Cadherin-3,Inverse variance weighted,10,0.97 [0.59-1.62],0.921958945778128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MARCO,Macrophage receptor MARCO,Inverse variance weighted,27,0.99 [0.74-1.32],0.923234807911811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.96 [0.43-2.16],0.923883986855426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.96 [0.43-2.15],0.924661939449267,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,0.99 [0.83-1.19],0.925045554283678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.91 [0.13-6.33],0.927295236991376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.97 [0.53-1.78],0.92756584664006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.98 [0.58-1.65],0.929023103211985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,0.98 [0.6-1.59],0.929161028694197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,19,1.01 [0.79-1.29],0.929477636769275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.02 [0.64-1.62],0.930429752539211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.02 [0.64-1.62],0.930637900484135,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CTSD,Cathepsin D,Inverse variance weighted,7,1.02 [0.57-1.83],0.93381642392702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1.02 [0.7-1.48],0.93478555041451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,RSPO3,R-spondin-3,Inverse variance weighted,5,0.97 [0.52-1.84],0.935429941557265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,0.94 [0.23-3.86],0.93545002299177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.96 [0.37-2.48],0.937304773943202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1.01 [0.76-1.35],0.939702876669033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,0.97 [0.39-2.41],0.941457111773615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPON2,Spondin-2,Inverse variance weighted,3,1.04 [0.38-2.81],0.94336857377803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.08 [0.13-9.15],0.945970732945725,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,0.99 [0.73-1.35],0.946814698777385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,35,0.99 [0.85-1.16],0.948154039463028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.99 [0.68-1.44],0.949168054735445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL10,Interleukin-10,Inverse variance weighted,4,1.01 [0.74-1.39],0.952745254285119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,Inverse variance weighted,59,1 [0.9-1.1],0.95340051522125,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,1.04 [0.22-5.01],0.956332139193764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PTH,Parathyroid hormone,Inverse variance weighted,11,1.01 [0.69-1.48],0.956336615690284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,0.99 [0.8-1.24],0.957614250379326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,15,0.99 [0.68-1.44],0.960398970602841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,0.99 [0.74-1.33],0.961113804591148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,1.01 [0.71-1.43],0.964160786542495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CPA2,Carboxypeptidase A2,Inverse variance weighted,10,0.99 [0.58-1.69],0.96457622351102,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.01 [0.54-1.9],0.966699057864021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.99 [0.71-1.38],0.967410188721791,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1 [0.9-1.12],0.968776603916353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ITGAV,Integrin alpha-V,Inverse variance weighted,10,1.01 [0.62-1.65],0.972890567116077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,VWC2,Brorin,Inverse variance weighted,12,0.99 [0.55-1.77],0.973107714169846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,NRP1,Neuropilin-1,Inverse variance weighted,14,0.99 [0.68-1.46],0.975191192108855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1 [0.8-1.25],0.97951935310591,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,AREG,Amphiregulin,Inverse variance weighted,5,0.99 [0.51-1.93],0.981817884833302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,17,1 [0.72-1.41],0.982102502275803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.02 [0.17-6.25],0.982986680559294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,13,1 [0.71-1.43],0.983471861954458,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,GOLM2,Protein GOLM2,Inverse variance weighted,14,1 [0.79-1.27],0.984172528845851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPRR3,Small proline-rich protein 3,Inverse variance weighted,6,1.01 [0.57-1.76],0.985822525072767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1 [0.69-1.43],0.987380399317076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,1 [0.52-1.9],0.98795173062414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1 [0.53-1.88],0.990564291838686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,CLGN,Calmegin,Inverse variance weighted,6,1 [0.67-1.49],0.992789394325827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PGF,Placenta growth factor,Inverse variance weighted,5,1 [0.55-1.81],0.993619535553957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,0.99 [0.24-4.19],0.99381519880647,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SPP1,Osteopontin,Inverse variance weighted,13,1 [0.57-1.74],0.994388753260944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1 [0.61-1.65],0.997232439936412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,PCDHB15,Protocadherin beta-15,Inverse variance weighted,19,1 [0.8-1.25],0.997969239630446,trans
